Clicky

Friday, November 20, 2026
All public companies · Official EDGAR

BBIOBridgeBio Pharma, Inc.

Nasdaq · CIK 0001743881
Filer categoryLarge accelerated filer
Entity typeoperating
SIC2834 Pharmaceutical Preparations
FY end1231
XBRL facts435

Identity from submissions API

NameBridgeBio Pharma, Inc.
CIK0001743881
TickersBBIO
ExchangesNasdaq
Entity typeoperating
CategoryLarge accelerated filer
SIC2834 Pharmaceutical Preparations
EIN000000000
LEI—
Fiscal year end1231
State of incorporationDE DE
Phone(650) 391-9740
Website—
Investor website—
Owner org03 Life Sciences
Flags—
Description—
Insider transactions (issuer)1
Insider transactions (owner)1

Former names

  • BridgeBio Pharma LLC (2018-06-19T00:00:00.000Z → 2019-05-16T00:00:00.000Z)
Business address
3160 PORTER DR.
SUITE 250
PALO ALTO
CA
94304
CA
Mailing address
3160 PORTER DR.
SUITE 250
PALO ALTO
CA
94304
CA

EDGAR has no company-logo API. Website field is shown when the filer provided one.

Financialist coverage

SEC filings

840 filing rows loaded from submissions recent.

FiledFormDocumentItemsAccessionFile no.FilmActSizeXBRLiXBRL
2026-11-20 4 FORM 4 0001743881-26-000045 16958
2026-11-19 144 xsl144X01/primary_doc.xml 0001950047-26-011359 001-38959 261575210 33 7864
2026-11-18 4 FORM 4 0001743881-26-000043 5035
2026-11-18 4 FORM 4 0001743881-26-000041 5060
2026-11-18 4 FORM 4 0001743881-26-000039 23084
2026-11-18 144 xsl144X01/primary_doc.xml 0001950047-26-011299 001-38959 261571018 33 7140
2026-11-12 SCHEDULE 13G/A xslSCHEDULE_13G_X02/primary_doc.xml 0000908834-26-000518 005-91059 261543231 34 28228
2026-11-03 4 FORM 4 0001470831-26-000976 4959
2026-10-29 10-Q 10-Q 0001743881-26-000034 001-38959 261502597 34 13524960 1 1
2026-10-29 8-K 8-K 2.02,9.01 0001743881-26-000033 001-38959 261501569 34 479018 1 1
2026-10-27 SCHEDULE 13G xslSCHEDULE_13G_X02/primary_doc.xml 0002012383-26-003764 005-91059 261491603 34 11177
2026-10-13 8-K 8-K 8.01,9.01 0001140361-26-039334 001-38959 261454256 34 169859 1 1
2026-09-21 4 FORM 4 0001470831-26-000897 10476
2026-08-31 8-K 8-K 8.01,9.01 0001140361-26-035055 001-38959 261346201 34 186123 1 1
2026-08-20 4 FORM 4 0001470831-26-000848 18912
2026-08-19 144 xsl144X01/primary_doc.xml 0001950047-26-008424 001-38959 261295796 33 9405
2026-08-18 4 FORM 4 0001470831-26-000837 5311
2026-08-18 4 FORM 4 0001470831-26-000836 23481
2026-08-18 4 FORM 4 0001470831-26-000835 5060
2026-08-18 144 xsl144X01/primary_doc.xml 0001950047-26-008337 001-38959 261291073 33 8629
2026-08-17 SCHEDULE 13D/A xslSCHEDULE_13D_X02/primary_doc.xml 0001140361-26-033404 005-91059 261287726 34 32269
2026-08-17 144 xsl144X01/primary_doc.xml 0001950047-26-008246 001-38959 261287126 33 5629
2026-08-17 8-K 8-K 1.01,8.01,9.01 0001140361-26-033282 001-38959 261285025 34 477665 1 1
2026-08-14 424B7 424B7 0001140361-26-032934 333-297701 261275960 33 455032
2026-08-10 10-Q 10-Q 0001743881-26-000027 001-38959 261258944 34 12760771 1 1
2026-08-10 8-K 8-K 2.02,9.01 0001743881-26-000026 001-38959 261258304 34 450227 1 1
2026-08-03 4 FORM 4 0001470831-26-000745 4959
2026-08-03 SCHEDULE 13G/A xslSCHEDULE_13G_X02/primary_doc.xml 0000908834-26-000369 005-91059 261230558 34 47495
2026-07-27 SCHEDULE 13G/A xslSCHEDULE_13G_X02/primary_doc.xml 0002012383-26-002210 005-91059 261206058 34 11243
2026-07-24 S-3ASR S-3ASR 0001140361-26-029624 333-297701 261202366 33 959668 1 1
2026-07-24 S-8 S-8 0001140361-26-029623 333-297699 261202340 33 206865 1 1
2026-07-22 8-K 8-K 8.01,9.01 0001140361-26-029291 001-38959 261194074 34 165206 1 1
2026-07-13 4 FORM 4 0001470831-26-000709 8692
2026-07-13 4 FORM 4 0001470831-26-000708 17593
2026-07-10 SCHEDULE 13D/A xslSCHEDULE_13D_X02/primary_doc.xml 0000905148-26-003237 005-91059 261169741 34 43759
2026-07-09 144 xsl144X01/primary_doc.xml 0001950047-26-006979 001-38959 261165925 33 7179
2026-07-09 144 xsl144X01/primary_doc.xml 0001950047-26-006976 001-38959 261165795 33 4911
2026-07-02 8-K 8-K 1.01,3.02,3.03,5.03,7.01,9.01 0001140361-26-027445 001-38959 261151667 34 1161204 1 1
2026-06-26 8-K 8-K 5.02,5.07,9.01 0001140361-26-026506 001-38959 261123960 34 548976 1 1
2026-06-24 4 FORM 4 0001470831-26-000636 18046
2026-06-24 4 FORM 4 0001470831-26-000635 14744
2026-06-24 4 FORM 4 0001470831-26-000634 8199
2026-06-24 4 FORM 4 0001470831-26-000633 7493
2026-06-24 4 FORM 4 0001470831-26-000632 534699
2026-06-24 4 FORM 4 0001470831-26-000631 7545
2026-06-24 4 FORM 4 0001470831-26-000630 7484
2026-06-24 4 FORM 4 0001470831-26-000629 535107
2026-06-24 4 FORM 4 0001470831-26-000628 489559
2026-06-24 4 FORM 4 0001470831-26-000627 9154
2026-06-24 4 FORM 4 0001470831-26-000626 537325
2026-06-24 4 FORM 4 0001470831-26-000625 483600
2026-06-24 144 xsl144X01/primary_doc.xml 0001950047-26-006457 001-38959 261116336 33 5623
2026-06-24 144 xsl144X01/primary_doc.xml 0001950047-26-006442 001-38959 261115942 33 6427
2026-06-23 4 FORM 4 0001470831-26-000569 5013
2026-06-23 144 xsl144X01/primary_doc.xml 0001950047-26-006434 001-38959 261111527 33 5682
2026-06-23 144 xsl144X01/primary_doc.xml 0001950047-26-006404 001-38959 261110989 33 5629
2026-06-22 144 xsl144X01/primary_doc.xml 0001950047-26-006349 001-38959 261107043 33 4872
2026-06-17 4 FORM 4 0001470831-26-000550 542228
2026-06-15 144 xsl144X01/primary_doc.xml 0001950047-26-006155 001-38959 261092113 33 6107
2026-06-08 4 FORM 4 0001470831-26-000523 30749
2026-05-29 SCHEDULE 13G xslSCHEDULE_13G_X02/primary_doc.xml 0000908834-26-000252 005-91059 261045546 34 56645
2026-05-27 8-K 8-K 8.01,9.01 0001140361-26-022979 001-38959 261026012 34 184406 1 1
2026-05-26 4 FORM 4 0001470831-26-000488 14700
2026-05-21 144 xsl144X01/primary_doc.xml 0001950047-26-004909 001-38959 261009066 33 13794
2026-05-19 4 FORM 4 0001470831-26-000473 8877
2026-05-19 4 FORM 4 0001470831-26-000472 22027
2026-05-19 4 FORM 4 0001470831-26-000471 5059
2026-05-19 4 FORM 4 0001470831-26-000470 14973
2026-05-18 144 xsl144X01/primary_doc.xml 0001950047-26-004675 001-38959 26993717 33 4880
2026-05-15 SCHEDULE 13G/A xslSCHEDULE_13G_X02/primary_doc.xml 0001274173-26-000133 005-91059 26984889 34 12199
2026-05-13 8-K 8-K 8.01,9.01 0001140361-26-021036 001-38959 26973095 34 185385 1 1
2026-05-11 4 FORM 4 0001470831-26-000423 26992
2026-05-08 8-K FORM 8-K 1.01,1.02,9.01 0001140361-26-019761 001-38959 26956265 34 164820 1 1
2026-05-08 S-3ASR S-3ASR 0001140361-26-019654 333-295678 26955785 33 2246654 1 1
2026-05-07 10-Q 10-Q 0001743881-26-000019 001-38959 26954101 34 11077786 1 1
2026-05-07 8-K 8-K 2.02,8.01 0001743881-26-000018 001-38959 26952993 34 389725 1 1
2026-05-04 4 FORM 4 0001470831-26-000410 4958
2026-04-24 ARS ARS 0001140361-26-016725 001-38959 26894564 34 2850613
2026-04-24 DEFA14A DEFA14A 0001140361-26-016724 001-38959 26894554 34 3396303
2026-04-24 DEF 14A DEF 14A 0001140361-26-016723 001-38959 26894519 34 8301648 1 1
2026-04-16 SCHEDULE 13G/A xslSCHEDULE_13G_X01/primary_doc.xml 0001470831-26-000373 005-91059 26868050 34 8922
2026-04-13 4 FORM 4 0001470831-26-000361 21064
2026-04-09 144 xsl144X01/primary_doc.xml 0001950047-26-003358 001-38959 26851914 33 11604
2026-04-02 SCHEDULE 13D/A xslSCHEDULE_13D_X02/primary_doc.xml 0000905148-26-001499 005-91059 26836079 34 38908
2026-03-30 8-K 8-K 8.01,9.01 0001140361-26-011991 001-38959 26813212 34 182268 1 1
2026-03-26 SCHEDULE 13G/A xslSCHEDULE_13G_X02/primary_doc.xml 0000102909-26-000828 005-91059 26798892 34 7248
2026-03-20 4 FORM 4 0001470831-26-000304 5384
2026-03-20 4 FORM 4 0001470831-26-000302 5411
2026-03-19 4 FORM 4 0001470831-26-000296 8195
2026-03-16 4 FORM 4 0001470831-26-000275 24682
2026-03-13 144 xsl144X01/primary_doc.xml 0001950047-26-002594 001-38959 26752813 33 13792
2026-03-12 4 FORM 4 0001470831-26-000260 9077
2026-03-10 144 xsl144X01/primary_doc.xml 0001950047-26-002400 001-38959 26739139 33 5625
2026-03-06 4 FORM 4 0001470831-26-000252 8835
2026-03-04 144 xsl144X01/primary_doc.xml 0001950047-26-002147 001-38959 26721535 33 4910
2026-03-03 4 FORM 4 0001470831-26-000236 11313
2026-02-27 144 xsl144X01/primary_doc.xml 0001950047-26-001893 001-38959 26700287 33 4872
2026-02-27 4 FORM 4 0001470831-26-000225 4818
2026-02-24 10-K 10-K 0001743881-26-000009 001-38959 26672588 34 18148397 1 1
2026-02-24 8-K 8-K 2.02,9.01 0001743881-26-000008 001-38959 26671506 34 449534 1 1
2026-02-23 4 FORM 4 0001470831-26-000214 10875
2026-02-19 144 xsl144X01/primary_doc.xml 0001950047-26-001512 001-38959 26654766 33 15227
2026-02-18 4 FORM 4 0001470831-26-000188 18174
2026-02-18 4 FORM 4 0001470831-26-000186 6759
2026-02-18 4 FORM 4 0001470831-26-000184 8295
2026-02-18 4 FORM 4 0001470831-26-000182 13387
2026-02-17 SCHEDULE 13D/A xslSCHEDULE_13D_X01/primary_doc.xml 0000905148-26-000914 005-91059 26644902 34 59384
2026-02-17 144 xsl144X01/primary_doc.xml 0001950047-26-001375 001-38959 26642647 33 5143
2026-02-17 144 xsl144X01/primary_doc.xml 0001950047-26-001308 001-38959 26641019 33 4881
2026-02-17 SCHEDULE 13G xslSCHEDULE_13G_X01/primary_doc.xml 0001274173-26-000074 005-91059 26638891 34 11995
2026-02-12 4 FORM 4 0001470831-26-000118 28836
2026-02-12 8-K 8-K 8.01,9.01 0001140361-26-004995 001-38959 26626144 34 201832 1 1
2026-01-21 8-K 8-K 1.01,2.03,3.02,8.01,9.01 0001140361-26-001843 001-38959 26547875 34 2977649 1 1
2026-01-12 4 FORM 4 0001470831-26-000026 32995
2026-01-12 8-K 8-K 2.02,7.01,8.01,9.01 0001140361-26-000971 001-38959 26526760 34 8536350 1 1
2026-01-08 144 xsl144X01/primary_doc.xml 0001950047-26-000276 001-38959 26519894 33 13802
2026-01-08 144 xsl144X01/primary_doc.xml 0001950047-26-000275 001-38959 26519892 33 13792
2025-12-16 4 FORM 4 0001470831-25-000422 14586
2025-12-16 4 FORM 4 0001470831-25-000420 4916
2025-12-16 4 FORM 4 0001470831-25-000418 4941
2025-12-15 144 xsl144X01/primary_doc.xml 0001950047-25-010321 001-38959 251571916 33 14511
2025-12-10 4 FORM 4 0001470831-25-000392 4837
2025-12-08 4 FORM 4 0001470831-25-000386 24292
2025-11-24 4 FORM 4 0001470831-25-000366 10877
2025-11-20 144 xsl144X01/primary_doc.xml 0001950047-25-009146 001-38959 251503300 33 13794
2025-11-19 4 FORM 4 0001470831-25-000357 537579
2025-11-19 4 FORM 4 0001470831-25-000355 488349
2025-11-18 4 FORM 4 0001470831-25-000353 18175
2025-11-18 4 FORM 4 0001470831-25-000351 8754
2025-11-18 4 FORM 4 0001470831-25-000349 4941
2025-11-18 144 xsl144X01/primary_doc.xml 0001950047-25-009007 001-38959 251494632 33 5571
2025-11-17 144 xsl144X01/primary_doc.xml 0001950047-25-008990 001-38959 251492104 33 4980
2025-11-17 144 xsl144X01/primary_doc.xml 0001950047-25-008947 001-38959 251491377 33 4911
2025-11-17 144 xsl144X01/primary_doc.xml 0001950047-25-008929 001-38959 251491202 33 8735
2025-11-14 SCHEDULE 13D/A xslSCHEDULE_13D_X01/primary_doc.xml 0000905148-25-004059 005-91059 251487760 34 36985
2025-11-14 4 FORM 4 0001470831-25-000317 484332
2025-11-14 SCHEDULE 13G xslSCHEDULE_13G_X01/primary_doc.xml 0000080255-25-000848 005-91059 251483433 34 7678
2025-11-12 144 xsl144X01/primary_doc.xml 0001950047-25-008752 001-38959 251472567 33 4777
2025-11-10 4 FORM 4 0001470831-25-000302 27561
2025-11-07 4 FORM 4 0001470831-25-000297 481866
2025-11-06 144 xsl144X01/primary_doc.xml 0001950047-25-008535 001-38959 251459322 33 4878
2025-10-31 4 FORM 4 0001470831-25-000282 13962
2025-10-29 144 xsl144X01/primary_doc.xml 0001628280-25-047224 001-38959 251431402 33 5681
2025-10-29 4 FORM 4 0001470831-25-000278 5491
2025-10-29 10-Q 10-Q 0001743881-25-000012 001-38959 251430752 34 13586624 1 1
2025-10-29 8-K 8-K 8.01,9.01 0001140361-25-039705 001-38959 251430037 34 189010 1 1
2025-10-29 8-K 8-K 2.02,9.01 0001743881-25-000010 001-38959 251429907 34 444953 1 1
2025-10-27 8-K 8-K 8.01,9.01 0001140361-25-039463 001-38959 251420002 34 193136 1 1
2025-10-27 144 xsl144X01/primary_doc.xml 0001628280-25-046423 001-38959 251419933 33 5048
2025-10-16 4 4 0001193125-25-241634 001-41955 251398541 34 8243
2025-10-10 4 FORM 4 0001470831-25-000256 15590
2025-10-08 144 xsl144X01/primary_doc.xml 0001950047-25-007840 001-38959 251382515 33 11594
2025-10-08 144 xsl144X01/primary_doc.xml 0001950047-25-007839 001-38959 251382510 33 11603
2025-09-08 4 FORM 4 0001257809-25-000003 537636
2025-09-08 4 FORM 4 0001742485-25-000005 24686
2025-09-05 144 xsl144X01/primary_doc.xml 0001950047-25-006810 001-38959 251297261 33 5567
2025-08-22 4 4 0000950170-25-111011 4930
2025-08-22 4 4 0000950170-25-110993 8930
2025-08-21 144 xsl144X01/primary_doc.xml 0001950047-25-006160 001-38959 251240844 33 10139
2025-08-20 144 xsl144X01/primary_doc.xml 0001950047-25-006112 001-38959 251237111 33 11056
2025-08-19 4 4 0000950170-25-110276 4829
2025-08-19 4 4 0000950170-25-110274 8652
2025-08-19 4 4 0000950170-25-110271 15391
2025-08-18 3 3 0000950170-25-109842 001-41955 251228844 34 9335
2025-08-18 144 xsl144X01/primary_doc.xml 0001950047-25-005957 001-38959 251227890 33 6644
2025-08-14 SCHEDULE 13D/A xslSCHEDULE_13D_X01/primary_doc.xml 0000905148-25-003013 005-91059 251222044 34 75362
2025-08-12 4 4 0000950170-25-107510 19259
2025-08-11 4 4 0000950170-25-106751 15336
2025-08-11 4 4 0000950170-25-106741 29447
2025-08-11 144 xsl144X01/primary_doc.xml 0001950047-25-005610 001-38959 251202261 33 7168
2025-08-08 144 xsl144X01/primary_doc.xml 0001950047-25-005574 001-38959 251199378 33 4926
2025-08-07 4 4 0000950170-25-105185 19220
2025-08-05 S-8 S-8 0001140361-25-028885 333-289268 251186128 33 216158 1 1
2025-08-05 10-Q 10-Q 0000950170-25-103192 001-38959 251185861 34 24175453 1 1
2025-08-05 144 xsl144X01/primary_doc.xml 0001950047-25-005437 001-38959 251185359 33 4910
2025-08-05 8-K 8-K 2.02,9.01 0000950170-25-102985 001-38959 251184823 34 918019 1 1
2025-07-29 SCHEDULE 13G/A xslSCHEDULE_13G_X01/primary_doc.xml 0000932471-25-000753 005-91059 251159018 34 6294
2025-07-03 4 4 0000950170-25-093907 16663
2025-07-02 8-K 8-K 1.01,2.03 0001140361-25-024413 001-38959 251097599 34 161653 1 1
2025-07-01 SCHEDULE 13D/A xslSCHEDULE_13D_X01/primary_doc.xml 0000905148-25-002298 005-91059 251098018 34 52637
2025-07-01 4 xslF345X05/form4.xml 0000905148-25-002297 17816
2025-07-01 144 xsl144X01/primary_doc.xml 0001950047-25-004775 001-38959 251096867 33 6481
2025-07-01 144 xsl144X01/primary_doc.xml 0001950047-25-004774 001-38959 251096863 33 4982
2025-06-30 4 4 0000950170-25-091764 4432
2025-06-30 4 4 0000950170-25-091762 9628
2025-06-30 4/A 4/A 0000950170-25-091759 5146
2025-06-30 4/A 4/A 0000950170-25-091756 5944
2025-06-26 4 4 0000950170-25-090498 5817
2025-06-26 144 xsl144X01/primary_doc.xml 0001950047-25-004635 001-38959 251080599 33 7800
2025-06-26 144 xsl144X01/primary_doc.xml 0001950047-25-004634 001-38959 251080569 33 7822
2025-06-26 144 xsl144X01/primary_doc.xml 0001950047-25-004633 001-38959 251080497 33 7802
2025-06-26 144 xsl144X01/primary_doc.xml 0001950047-25-004632 001-38959 251080484 33 7841
2025-06-24 4 4 0000950170-25-089674 8116
2025-06-24 4 4 0000950170-25-089673 7396
2025-06-24 4 4 0000950170-25-089670 7424
2025-06-24 4 4 0000950170-25-089669 8148
2025-06-24 4 4 0000950170-25-089667 7366
2025-06-24 4 4 0000950170-25-089666 7459
2025-06-24 4 4 0000950170-25-089665 7419
2025-06-24 4 4 0000950170-25-089652 7371
2025-06-24 4 4 0000950170-25-089648 7419
2025-06-24 4 4 0000950170-25-089647 7456
2025-06-24 4 4 0000950170-25-089646 8572
2025-06-24 4 4 0000950170-25-089643 8051
2025-06-24 4 4 0000950170-25-089642 8156
2025-06-24 144 xsl144X01/primary_doc.xml 0002007317-25-000633 001-38959 251070366 33 4471
2025-06-23 8-K 8-K 3.03,5.03,5.07,9.01 0001140361-25-023362 001-38959 251065283 34 572433 1 1
2025-06-11 4 4 0000950170-25-084914 9039
2025-06-10 144 xsl144X01/primary_doc.xml 0001950047-25-004060 001-38959 251037014 33 4870
2025-05-20 4 4 0000950170-25-075425 20486
2025-05-20 4 4 0000950170-25-075346 4791
2025-05-20 4 4 0000950170-25-075340 4828
2025-05-19 144 xsl144X01/primary_doc.xml 0001950047-25-003199 001-38959 25964352 33 7180
2025-05-14 SCHEDULE 13D/A xslSCHEDULE_13D_X01/primary_doc.xml 0001140361-25-019024 005-91059 25947434 34 24903
2025-05-14 4 xslF345X05/form4.xml 0001140361-25-019003 40997
2025-05-12 144 xsl144X01/primary_doc.xml 0001140361-25-018460 001-38959 25936890 33 6576
2025-05-09 4 4 0000950170-25-068335 6509
2025-05-09 DEFA14A DEFA14A 0001140361-25-018190 001-38959 25931118 34 424220
2025-05-06 4 4 0000950170-25-064567 4481
2025-05-06 4 4 0000950170-25-064558 5596
2025-05-02 144 xsl144X01/primary_doc.xml 0001972362-25-000382 001-38959 25909269 33 4337
2025-04-30 DEFA14A DEFA14A 0001140361-25-016655 001-38959 25895346 34 8239143
2025-04-30 ARS ARS 0001140361-25-016454 001-38959 25890640 34 2952635
2025-04-30 DEF 14A DEF 14A 0001140361-25-016452 001-38959 25890632 34 8858645 1 1
2025-04-29 10-Q 10-Q 0000950170-25-060314 001-38959 25889072 34 19307191 1 1
2025-04-29 8-K 8-K 2.02,9.01 0000950170-25-060085 001-38959 25887064 34 705380 1 1
2025-04-24 4 4 0000950170-25-058102 7062
2025-04-16 4 4 0000950170-25-054883 8393
2025-04-16 PRE 14A PRE 14A 0001140361-25-014213 001-38959 25843496 34 8784425 1 1
2025-04-14 144 xsl144X01/primary_doc.xml 0001950047-25-002455 001-38959 25836281 33 5657
2025-04-03 4 4 0000950170-25-050584 8396
2025-04-02 144 xsl144X01/primary_doc.xml 0001950047-25-002341 001-38959 25805587 33 4910
2025-03-27 4 4 0000950170-25-046171 7063
2025-03-21 4 4 0000950170-25-043403 14640
2025-03-21 4 4 0000950170-25-043379 8007
2025-03-21 4 4 0000950170-25-043376 5240
2025-03-17 8-K 8-K 5.02,7.01,9.01 0001140361-25-009063 001-38959 25745011 34 177159 1 1
2025-03-12 SCHEDULE 13D/A xslSCHEDULE_13D_X01/primary_doc.xml 0000905148-25-000909 005-91059 25732108 34 19919
2025-03-10 4 4 0000950170-25-036420 9468
2025-03-07 SCHEDULE 13D/A xslSCHEDULE_13D_X01/primary_doc.xml 0001140361-25-007701 005-91059 25721578 34 15881
2025-03-07 4 FORM 4 0001140361-25-007699 34100
2025-03-06 144 xsl144X01/primary_doc.xml 0001950047-25-001613 001-38959 25715226 33 4878
2025-03-05 144 xsl144X01/primary_doc.xml 0001140361-25-007262 001-38959 25713364 33 6080
2025-02-28 8-K 8-K 1.01,1.02,2.03,3.02,8.01,9.01 0001140361-25-006524 001-38959 25690299 34 1298977 1 1
2025-02-27 3 3 0000950170-25-029402 3697
2025-02-27 4 4 0000950170-25-029262 10166
2025-02-27 4 4 0000950170-25-029228 9148
2025-02-25 144 xsl144X01/primary_doc.xml 0001950047-25-001237 001-38959 25664013 33 7207
2025-02-25 144 xsl144X01/primary_doc.xml 0001950047-25-001234 001-38959 25663988 33 6512
2025-02-20 10-K 10-K 0000950170-25-024119 001-38959 25645155 34 27676728 1 1
2025-02-20 8-K 8-K 2.02,9.01 0000950170-25-023741 001-38959 25643286 34 746651 1 1
2025-02-19 4 4 0000950170-25-023632 4815
2025-02-19 4 4 0000950170-25-023630 17943
2025-02-19 4 4 0000950170-25-023625 18666
2025-02-19 144 xsl144X01/primary_doc.xml 0001950047-25-001041 001-38959 25640702 33 6435
2025-02-19 144 xsl144X01/primary_doc.xml 0001950047-25-001040 001-38959 25640699 33 5554
2025-02-13 SCHEDULE 13G/A xslSCHEDULE_13G_X01/primary_doc.xml 0000950170-25-020045 005-91059 25621740 34 8072
2025-01-31 SCHEDULE 13D/A xslSCHEDULE_13D_X01/primary_doc.xml 0000905148-25-000308 005-91059 25580036 34 26612
2025-01-31 144 xsl144X01/primary_doc.xml 0000905148-25-000307 001-38959 25580033 33 6512
2025-01-31 4 xslF345X05/form4.xml 0000905148-25-000306 17760
2025-01-30 4 4 0000950170-25-011242 8701
2025-01-30 4 4 0000950170-25-011239 11250
2025-01-28 144 xsl144X01/primary_doc.xml 0001950047-25-000450 001-38959 25564442 33 5698
2025-01-28 144 xsl144X01/primary_doc.xml 0001950047-25-000449 001-38959 25564437 33 5560
2025-01-13 8-K 8-K 2.02,7.01,8.01,9.01 0001140361-25-000943 001-38959 25526887 34 7190745 1 1
2025-01-08 4/A 4/A 0000950170-25-003541 5332
2024-12-31 4 4 0000950170-24-141676 13460
2024-12-27 4 4 0000950170-24-140874 5167
2024-12-27 4 4 0000950170-24-140871 7263
2024-12-12 4 4 0000950170-24-135984 5739
2024-12-12 4 4 0000950170-24-135983 5644
2024-12-12 4 4 0000950170-24-135982 5211
2024-11-25 8-K 8-K 8.01,9.01 0001140361-24-047704 001-38959 241491713 34 207535 1 1
2024-11-20 4 4 0000950170-24-129455 8961
2024-11-20 4 4 0000950170-24-129452 5137
2024-11-19 4 4 0000950170-24-128910 15401
2024-11-19 4 4 0000950170-24-128903 4824
2024-11-19 4 4 0000950170-24-128888 15770
2024-11-19 144 xsl144X01/primary_doc.xml 0001950047-24-008807 001-38959 241476594 33 4831
2024-11-19 144 xsl144X01/primary_doc.xml 0001950047-24-008805 001-38959 241476496 33 4924
2024-11-12 SC 13G/A us10806x1028_111224.txt 0002012383-24-004337 005-91059 241445714 34 14072
2024-11-12 10-Q 10-Q 0000950170-24-124577 001-38959 241443327 34 17849677 1 1
2024-11-12 8-K 8-K 2.02,9.01 0000950170-24-124576 001-38959 241443316 34 602220 1 1
2024-11-06 SC 13D/A bbio.htm 0000905148-24-002952 005-91059 241432073 34 361924
2024-10-22 SC 13G/A us10806x1028_102224.txt 0002012383-24-001573 005-91059 241387291 34 14057
2024-09-17 4 FORM 4 0001140361-24-041329 19181
2024-09-17 SC 13D/A SC 13D/A 0001140361-24-041327 005-91059 241305712 34 373020
2024-09-13 144 xsl144X01/primary_doc.xml 0001140361-24-041079 001-38959 241298512 33 6080
2024-09-11 8-K 8-K 8.01,9.01 0001140361-24-040755 001-38959 241291073 34 194405 1 1
2024-08-21 8-K 8-K 1.01,9.01 0001140361-24-037974 001-38959 241226900 34 1578662 1 1
2024-08-20 SC 13D/A SC 13D/A 0001140361-24-037981 005-91059 241226917 34 366722
2024-08-20 4 4 0000950170-24-099275 19265
2024-08-20 4 4 0000950170-24-099269 19908
2024-08-20 4 4 0000950170-24-099267 4824
2024-08-19 144 xsl144X01/primary_doc.xml 0001950047-24-006225 001-38959 241220971 33 4834
2024-08-19 144 xsl144X01/primary_doc.xml 0001950047-24-006220 001-38959 241220940 33 4926
2024-08-08 4 4 0000950170-24-094117 7388
2024-08-01 S-8 S-8 0001140361-24-035364 333-281190 241167739 33 200313 1 1
2024-08-01 10-Q 10-Q 0000950170-24-089326 001-38959 241167124 34 20398477 1 1
2024-08-01 8-K 8-K 2.02,9.01 0000950170-24-088952 001-38959 241164288 34 600150 1 1
2024-07-29 3 3 0000950170-24-087461 17874
2024-07-23 8-K 8-K 5.02,7.01,9.01 0001140361-24-033856 001-38959 241134608 34 269261 1 1
2024-06-25 4 4 0000950170-24-077455 5371
2024-06-25 4 4 0000950170-24-077452 5458
2024-06-25 4 4 0000950170-24-077450 5434
2024-06-25 4 4 0000950170-24-077448 5383
2024-06-25 4 4 0000950170-24-077444 5474
2024-06-25 4 4 0000950170-24-077443 5410
2024-06-25 4 4 0000950170-24-077447 7244
2024-06-25 4 4 0000950170-24-077446 5410
2024-06-25 4 4 0000950170-24-077445 5424
2024-06-25 4 4 0000950170-24-077442 5471
2024-06-25 4 4 0000950170-24-077441 5373
2024-06-25 4 4 0000950170-24-077440 5437
2024-06-25 4 4 0000950170-24-077437 5379
2024-06-24 8-K 8-K 5.07,9.01 0001140361-24-031087 001-38959 241064197 34 329937 1 1
2024-06-06 8-K 8-K 8.01,9.01 0001140361-24-029050 001-38959 241023765 34 199394 1 1
2024-06-05 4 4 0000950170-24-069401 9400
2024-06-03 144 xsl144X01/primary_doc.xml 0001950047-24-004353 001-38959 241014398 33 4939
2024-05-17 4 4 0000950170-24-061646 17737
2024-05-17 4 4 0000950170-24-061638 18119
2024-05-02 10-Q 10-Q 0000950170-24-052165 001-38959 24908753 34 19757972 1 1
2024-05-02 8-K 8-K 2.02,9.01 0000950170-24-051573 001-38959 24905303 34 501105 1 1
2024-04-25 ARS ARS 0001140361-24-022037 001-38959 24876277 34 1946544
2024-04-25 DEFA14A DEFA14A 0001140361-24-022031 001-38959 24876171 34 3142305
2024-04-25 DEF 14A DEF 14A 0001140361-24-022023 001-38959 24876052 34 8307312 1 1
2024-03-14 4 4 0000950170-24-031433 8056
2024-03-14 4 4 0000950170-24-031431 8028
2024-03-06 424B5 424B5 0001140361-24-011764 333-271650 24727034 33 669465
2024-03-06 8-K FORM 8-K 1.01,8.01,9.01 0001140361-24-011766 001-38959 24726988 34 466228 1 1
2024-03-05 4 4 0000950170-24-025839 5422
2024-03-04 424B5 424B5 0001140361-24-011117 333-271650 24716070 33 654814
2024-03-04 8-K 8-K 1.01 0001140361-24-010920 001-38959 24712813 34 167978 1 1
2024-02-22 10-K 10-K 0000950170-24-018811 001-38959 24665262 34 21537579 1 1
2024-02-22 8-K 8-K 2.02,9.01 0000950170-24-018431 001-38959 24662307 34 582427 1 1
2024-02-21 4 4 0000950170-24-017895 18404
2024-02-21 4 4 0000950170-24-017894 8988
2024-02-21 4 4 0000950170-24-017891 17747
2024-02-20 4 4 0000950170-24-017081 9138
2024-02-16 SC 13G/A SC 13G/A 0001140361-24-008424 005-91059 24650125 34 57660
2024-02-15 144 xsl144X01/primary_doc.xml 0001950047-24-000956 001-38959 24643824 33 6383
2024-02-13 SC 13G/A SCHEDULE 13G/A 0001104659-24-020469 005-91059 24627637 34 13143
2024-02-13 5 5 0000950170-24-014537 6681
2024-02-13 4 4 0000950170-24-014523 5998
2024-01-29 SC 13G/A us10806x1028_012924.txt 0001086364-24-005626 005-91059 24574967 34 13796
2024-01-23 SC 13G/A Bridgebio_Pharma_Inc.txt 0000093751-24-000091 005-91059 24550825 34 8595
2024-01-18 4 4 0000950170-24-005380 8468
2024-01-18 8-K 8-K 1.01,1.02,2.03 0001140361-24-002636 001-38959 24540121 34 185024 1 1
2024-01-16 144 xsl144X01/primary_doc.xml 0001950047-24-000288 001-38959 24535161 33 6382
2024-01-08 8-K 8-K 8.01,9.01 0001140361-24-001358 001-38959 24521033 34 5688024 1 1
2024-01-05 S-8 S-8 0001140361-24-001006 333-276393 24516266 33 278197
2023-12-28 4 FORM 4 SUBMISSION 0001209191-23-059885 6212
2023-12-26 144 xsl144X01/primary_doc.xml 0002002698-23-000189 001-38959 231514226 33 4478
2023-12-20 4 FORM 4 SUBMISSION 0001209191-23-059324 5745
2023-12-19 4 FORM 4 SUBMISSION 0001209191-23-059101 9007
2023-12-18 144 xsl144X01/primary_doc.xml 0001950047-23-006232 001-38959 231493915 33 5686
2023-12-15 144 xsl144X01/primary_doc.xml 0001950047-23-006122 001-38959 231490459 33 5549
2023-12-05 4 FORM 4 SUBMISSION 0001209191-23-057374 7389
2023-12-01 144 xsl144X01/primary_doc.xml 0001950047-23-005559 001-38959 231459814 33 5603
2023-11-22 SC 13D/A SC 13D/A 0001140361-23-054445 005-91059 231433664 34 362650
2023-11-20 4 FORM 4 SUBMISSION 0001209191-23-056015 21374
2023-11-20 4 FORM 4 SUBMISSION 0001209191-23-056012 22791
2023-11-20 4 FORM 4 SUBMISSION 0001209191-23-056011 9179
2023-11-17 144 xsl144X01/primary_doc.xml 0001950047-23-005157 001-38959 231419158 33 4751
2023-11-17 144 xsl144X01/primary_doc.xml 0001950047-23-005156 001-38959 231419149 33 4771
2023-11-17 4 FORM 4 SUBMISSION 0001209191-23-055717 8926
2023-11-15 144 xsl144X01/primary_doc.xml 0001950047-23-004995 001-38959 231410512 33 4797
2023-11-02 S-3ASR S-3ASR 0001140361-23-051194 333-275280 231373387 33 526588
2023-11-02 10-Q 10-Q 0000950170-23-058255 001-38959 231372721 34 19002054 1 1
2023-11-02 8-K 8-K 2.02,9.01 0000950170-23-057745 001-38959 231370093 34 749103 1 1
2023-09-25 8-K 8-K 1.01,3.02,7.01,9.01 0000950170-23-049683 001-38959 231275824 34 799222 1 1
2023-09-07 4 FORM 4 SUBMISSION 0001209191-23-048595 5664
2023-09-05 144 xsl144X01/primary_doc.xml 0001950047-23-003687 001-38959 231235902 33 4884
2023-08-18 4 FORM 4 SUBMISSION 0001209191-23-046514 9428
2023-08-18 4 FORM 4 SUBMISSION 0001209191-23-046512 21624
2023-08-18 4 FORM 4 SUBMISSION 0001209191-23-046511 20814
2023-08-17 144 xsl144X01/primary_doc.xml 0001950047-23-003218 001-38959 231182005 33 4832
2023-08-17 144 xsl144X01/primary_doc.xml 0001950047-23-003217 001-38959 231182002 33 4741
2023-08-03 10-Q 10-Q 0000950170-23-037977 001-38959 231140097 34 21320212 1 1
2023-08-03 8-K 8-K 2.02,9.01 0000950170-23-037590 001-38959 231138088 34 833259 1 1
2023-07-26 S-3ASR S-3ASR 0001140361-23-036235 333-273452 231113549 33 380310
2023-07-20 SC 13D/A SC 13D/A 0001140361-23-035291 005-91059 231097967 34 364683
2023-07-19 4 xslF345X05/form4.xml 0001140361-23-035288 17325
2023-07-18 144 xsl144X01/primary_doc.xml 0001140361-23-035097 001-38959 231095443 33 6615
2023-07-18 CT ORDER filename1.pdf 20230718,20230718 9999999997-23-003562 333-231759 231093002 33 126865
2023-07-17 8-K 8-K 7.01,8.01,9.01 0001140361-23-034684 001-38959 231090505 34 4229915 1 1
2023-06-23 4 FORM 4 SUBMISSION 0001209191-23-039396 5561
2023-06-23 4 FORM 4 SUBMISSION 0001209191-23-039393 5648
2023-06-23 4 FORM 4 SUBMISSION 0001209191-23-039391 5624
2023-06-23 4 FORM 4 SUBMISSION 0001209191-23-039387 5573
2023-06-23 4 FORM 4 SUBMISSION 0001209191-23-039385 5600
2023-06-23 4 FORM 4 SUBMISSION 0001209191-23-039380 5614
2023-06-23 4 FORM 4 SUBMISSION 0001209191-23-039375 5664
2023-06-23 4 FORM 4 SUBMISSION 0001209191-23-039369 5592
2023-06-23 4 FORM 4 SUBMISSION 0001209191-23-039361 5661
2023-06-23 4 FORM 4 SUBMISSION 0001209191-23-039352 5563
2023-06-23 4 FORM 4 SUBMISSION 0001209191-23-039347 5627
2023-06-23 4 FORM 4 SUBMISSION 0001209191-23-039342 5569
2023-06-22 8-K 8-K 5.07,9.01 0001140361-23-030932 001-38959 231033343 34 185821 1 1
2023-05-18 4 FORM 4 SUBMISSION 0001209191-23-030599 21196

Latest XBRL company facts

One latest value per concept from companyfacts (435 concepts). Full history stays in the JSON.

TaxonomyTagLabelUnitValueStartEndFYFPFormFiledAccn
dei EntityCommonStockSharesOutstanding Entity Common Stock, Shares Outstanding shares 194.80M 2026-10-22 2026 Q3 10-Q 2026-10-29 0001743881-26-000034
dei EntityPublicFloat Entity Public Float USD 7.30B 2025-06-30 2025 FY 10-K 2026-02-24 0001743881-26-000009
ecd CoSelectedMeasureAmt CoSelectedMeasureAmt USD 502.08M 2025-01-01 2025-12-31 DEF 14A 2026-04-24 0001140361-26-016723
ecd NonPeoNeoAvgCompActuallyPaidAmt NonPeoNeoAvgCompActuallyPaidAmt USD 22.56M 2025-01-01 2025-12-31 DEF 14A 2026-04-24 0001140361-26-016723
ecd NonPeoNeoAvgTotalCompAmt NonPeoNeoAvgTotalCompAmt USD 3.26M 2025-01-01 2025-12-31 DEF 14A 2026-04-24 0001140361-26-016723
ecd PeerGroupTotalShareholderRtnAmt PeerGroupTotalShareholderRtnAmt USD 125 2025-01-01 2025-12-31 DEF 14A 2026-04-24 0001140361-26-016723
ecd PeoActuallyPaidCompAmt PeoActuallyPaidCompAmt USD 75.35M 2025-01-01 2025-12-31 DEF 14A 2026-04-24 0001140361-26-016723
ecd PeoTotalCompAmt PeoTotalCompAmt USD 14.94M 2025-01-01 2025-12-31 DEF 14A 2026-04-24 0001140361-26-016723
ecd TotalShareholderRtnAmt TotalShareholderRtnAmt USD 108 2025-01-01 2025-12-31 DEF 14A 2026-04-24 0001140361-26-016723
ffd NetFeeAmt NetFeeAmt USD 22,308.68 2026-07-24 S-8 2026-07-24 0001140361-26-029623
ffd TtlFeeAmt TtlFeeAmt USD 22,308.68 2026-07-24 S-8 2026-07-24 0001140361-26-029623
ffd TtlOfferingAmt TtlOfferingAmt USD 161.54M 2026-07-24 S-8 2026-07-24 0001140361-26-029623
ffd TtlOffsetAmt TtlOffsetAmt USD 0 2026-07-24 S-8 2026-07-24 0001140361-26-029623
ffd TtlPrevslyPdAmt TtlPrevslyPdAmt USD 0 2026-07-24 S-3ASR 2026-07-24 0001140361-26-029624
us-gaap AccountsPayableCurrent Accounts Payable, Current USD 88.26M 2026-09-30 2026 Q3 10-Q 2026-10-29 0001743881-26-000034
us-gaap AccountsReceivableNetCurrent Accounts Receivable, after Allowance for Credit Loss, Current USD 375.09M 2026-09-30 2026 Q3 10-Q 2026-10-29 0001743881-26-000034
us-gaap AccretionAmortizationOfDiscountsAndPremiumsInvestments Accretion (Amortization) of Discounts and Premiums, Investments USD 69,000 2019-01-01 2019-09-30 2019 Q3 10-Q 2019-11-08 0001564590-19-041986
us-gaap AccretionExpense Accretion Expense USD 53.11M 2025-01-01 2025-06-30 2025 Q2 10-Q 2025-08-05 0000950170-25-103192
us-gaap AccruedLiabilitiesCurrent Accrued Liabilities, Current USD 8.69M 2020-09-30 2020 Q3 10-Q 2020-11-05 0001564590-20-051460
us-gaap AccruedProfessionalFeesCurrent Accrued Professional Fees, Current USD 8.94M 2026-09-30 2026 Q3 10-Q 2026-10-29 0001743881-26-000034
us-gaap AccumulatedOtherComprehensiveIncomeLossNetOfTax Accumulated Other Comprehensive Income (Loss), Net of Tax USD -95,000 2026-09-30 2026 Q3 10-Q 2026-10-29 0001743881-26-000034
us-gaap AdditionalPaidInCapital Additional Paid in Capital USD 2.17B 2026-09-30 2026 Q3 10-Q 2026-10-29 0001743881-26-000034
us-gaap AdditionalPaidInCapitalCommonStock Additional Paid in Capital, Common Stock USD 1.98B 2025-06-30 2025 Q2 10-Q 2025-08-05 0000950170-25-103192
us-gaap AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation Share-based Payment Arrangement, Decrease for Tax Withholding Obligation USD 5.09M 2026-07-01 2026-09-30 2026 Q3 10-Q 2026-10-29 0001743881-26-000034
us-gaap AdjustmentsToAdditionalPaidInCapitalDividendsInExcessOfRetainedEarnings Adjustments to Additional Paid in Capital, Dividends in Excess of Retained Earnings USD 16.37M 2026-07-01 2026-09-30 2026 Q3 10-Q 2026-10-29 0001743881-26-000034
us-gaap AdjustmentsToAdditionalPaidInCapitalEquityComponentOfConvertibleDebtSubsequentAdjustments Adjustments to Additional Paid in Capital, Equity Component of Convertible Debt, Subsequent Adjustments USD 168.08M 2020-01-01 2020-12-31 2022 FY 10-K 2023-02-23 0000950170-23-004145
us-gaap AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationEmployeeStockPurchaseProgramRequisiteServicePeriodRecognition APIC, Share-based Payment Arrangement, ESPP, Increase for Cost Recognition USD 351,000 2019-01-01 2019-12-31 2019 FY 10-K 2020-03-03 0001564590-20-008260
us-gaap AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue APIC, Share-based Payment Arrangement, Increase for Cost Recognition USD 39.21M 2026-07-01 2026-09-30 2026 Q3 10-Q 2026-10-29 0001743881-26-000034
us-gaap AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationRestrictedStockUnitsRequisiteServicePeriodRecognition APIC, Share-based Payment Arrangement, Restricted Stock Unit, Increase for Cost Recognition USD 69,000 2019-04-01 2019-06-30 2019 Q3 10-Q 2019-11-08 0001564590-19-041986
us-gaap AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition APIC, Share-based Payment Arrangement, Option, Increase for Cost Recognition USD 11.75M 2020-07-01 2020-09-30 2020 Q3 10-Q 2020-11-05 0001564590-20-051460
us-gaap AdvertisingExpense Advertising Expense USD 110.10M 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-24 0001743881-26-000009
us-gaap AllocatedShareBasedCompensationExpense Share-based Payment Arrangement, Expense USD 117.74M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-10-29 0001743881-26-000034
us-gaap AllowanceForDoubtfulAccountsReceivable Accounts Receivable, Allowance for Credit Loss USD 0 2024-12-31 2024 FY 10-K 2025-02-20 0000950170-25-024119
us-gaap AllowanceForDoubtfulAccountsReceivableCurrent Accounts Receivable, Allowance for Credit Loss, Current USD 8.30M 2025-12-31 2025 FY 10-K 2026-02-24 0001743881-26-000009
us-gaap AmortizationOfDebtDiscountPremium Amortization of Debt Discount (Premium) USD 2.39M 2021-01-01 2021-09-30 2021 Q3 10-Q 2021-11-04 0000950170-21-003080
us-gaap AmortizationOfFinancingCosts Amortization of Debt Issuance Costs USD 70,000 2021-01-01 2021-09-30 2021 Q3 10-Q 2021-11-04 0000950170-21-003080
us-gaap AmortizationOfFinancingCostsAndDiscounts Amortization of Debt Issuance Costs and Discounts USD 5.67M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-10-29 0001743881-26-000034
us-gaap AmortizationOfIntangibleAssets Amortization of Intangible Assets USD 2.10M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-10-29 0001743881-26-000034
us-gaap AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount shares 64.46M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-10-29 0001743881-26-000034
us-gaap Assets Assets USD 2.16B 2026-09-30 2026 Q3 10-Q 2026-10-29 0001743881-26-000034
us-gaap AssetsCurrent Assets, Current USD 2.04B 2026-09-30 2026 Q3 10-Q 2026-10-29 0001743881-26-000034
us-gaap AssetsFairValueDisclosure Assets, Fair Value Disclosure USD 1.22B 2026-09-30 2026 Q3 10-Q 2026-10-29 0001743881-26-000034
us-gaap AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax Debt Securities, Available-for-sale, Accumulated Gross Unrealized Gain, before Tax USD 0 2026-09-30 2026 Q3 10-Q 2026-10-29 0001743881-26-000034
us-gaap AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax Debt Securities, Available-for-sale, Accumulated Gross Unrealized Loss, before Tax USD 0 2026-09-30 2026 Q3 10-Q 2026-10-29 0001743881-26-000034
us-gaap AvailableForSaleDebtSecuritiesAmortizedCostBasis Debt Securities, Available-for-sale, Amortized Cost USD 5.49M 2026-09-30 2026 Q3 10-Q 2026-10-29 0001743881-26-000034
us-gaap AvailableForSaleSecuritiesContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss Available-for-sale Securities, Continuous Unrealized Loss Position, 12 Months or Longer, Accumulated Loss USD 0 2021-09-30 2021 Q3 10-Q 2021-11-04 0000950170-21-003080
us-gaap AvailableForSaleSecuritiesDebtSecurities Debt Securities, Available-for-sale USD 5.49M 2026-09-30 2026 Q3 10-Q 2026-10-29 0001743881-26-000034
us-gaap AvailableForSaleSecuritiesDebtSecuritiesCurrent Debt Securities, Available-for-sale, Current USD 5.49M 2026-09-30 2026 Q3 10-Q 2026-10-29 0001743881-26-000034
us-gaap AvailableForSaleSecuritiesGrossRealizedGainLossNet Available-for-sale Securities, Gross Realized Gain (Loss) USD 0 2021-01-01 2021-09-30 2021 Q3 10-Q 2021-11-04 0000950170-21-003080
us-gaap BusinessExitCosts1 Business Exit Costs USD 16.68M 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-24 0001743881-26-000009
us-gaap CapitalExpendituresIncurredButNotYetPaid Capital Expenditures Incurred but Not yet Paid USD 12,000 2026-01-01 2026-03-31 2026 Q1 10-Q 2026-05-07 0001743881-26-000019
us-gaap CashAcquiredFromAcquisition Cash Acquired from Acquisition USD 784,000 2019-01-01 2019-09-30 2020 Q3 10-Q 2020-11-05 0001564590-20-051460
us-gaap CashAndCashEquivalentsAtCarryingValue Cash and Cash Equivalents, at Carrying Value USD 1.53B 2026-09-30 2026 Q3 10-Q 2026-10-29 0001743881-26-000034
us-gaap CashAndCashEquivalentsFairValueDisclosure Cash and Cash Equivalents, Fair Value Disclosure USD 1.22B 2026-09-30 2026 Q3 10-Q 2026-10-29 0001743881-26-000034
us-gaap CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents USD 1.54B 2026-09-30 2026 Q3 10-Q 2026-10-29 0001743881-26-000034
us-gaap CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Including Disposal Group and Discontinued Operations USD 1.54B 2026-09-30 2026 Q3 10-Q 2026-10-29 0001743881-26-000034
us-gaap CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect USD 963.35M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-10-29 0001743881-26-000034
us-gaap CashDivestedFromDeconsolidation Cash Divested from Deconsolidation USD 0 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-24 0001743881-26-000009
us-gaap CashEquivalentsAtCarryingValue Cash Equivalents, at Carrying Value USD 1.22B 2026-09-30 2026 Q3 10-Q 2026-10-29 0001743881-26-000034
us-gaap CommonStockParOrStatedValuePerShare Common Stock, Par or Stated Value Per Share USD/shares 0.001 2026-09-30 2026 Q3 10-Q 2026-10-29 0001743881-26-000034
us-gaap CommonStockSharesAuthorized Common Stock, Shares Authorized shares 500.00M 2026-09-30 2026 Q3 10-Q 2026-10-29 0001743881-26-000034
us-gaap CommonStockSharesIssued Common Stock, Shares, Issued shares 207.30M 2026-09-30 2026 Q3 10-Q 2026-10-29 0001743881-26-000034
us-gaap CommonStockSharesOutstanding Common Stock, Shares, Outstanding shares 196.00M 2026-09-30 2026 Q3 10-Q 2026-10-29 0001743881-26-000034
us-gaap CommonStockValue Common Stock, Value, Issued USD 207,000 2026-09-30 2026 Q3 10-Q 2026-10-29 0001743881-26-000034
us-gaap ComprehensiveIncomeNetOfTax Comprehensive Income (Loss), Net of Tax, Attributable to Parent USD -373.08M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-10-29 0001743881-26-000034
us-gaap ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest Comprehensive Income (Loss), Net of Tax, Attributable to Noncontrolling Interest USD -9.97M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-10-29 0001743881-26-000034
us-gaap ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest Comprehensive Income (Loss), Net of Tax, Including Portion Attributable to Noncontrolling Interest USD -383.05M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-10-29 0001743881-26-000034
us-gaap ConstructionInProgressExpendituresIncurredButNotYetPaid Construction in Progress Expenditures Incurred but Not yet Paid USD 8.00M 2019-01-01 2019-12-31 2021 FY 10-K 2022-02-25 0000950170-22-002030
us-gaap ContractualObligation Contractual Obligation USD 2.03B 2025-06-30 2025 Q2 10-Q 2025-08-05 0000950170-25-103192
us-gaap ContractualObligationDueAfterFifthYear Contractual Obligation, to be Paid, after Year Five USD 580.03M 2025-06-30 2025 Q2 10-Q 2025-08-05 0000950170-25-103192
us-gaap ContractualObligationDueInFifthYear Contractual Obligation, to be Paid, Year Five USD 10.06M 2025-06-30 2025 Q2 10-Q 2025-08-05 0000950170-25-103192
us-gaap ContractualObligationDueInFourthYear Contractual Obligation, to be Paid, Year Four USD 765.97M 2025-06-30 2025 Q2 10-Q 2025-08-05 0000950170-25-103192
us-gaap ContractualObligationDueInNextTwelveMonths Contractual Obligation, to be Paid, Year One USD 40.63M 2025-06-30 2025 Q2 10-Q 2025-08-05 0000950170-25-103192
us-gaap ContractualObligationDueInSecondYear Contractual Obligation, to be Paid, Year Two USD 583.76M 2025-06-30 2025 Q2 10-Q 2025-08-05 0000950170-25-103192
us-gaap ContractualObligationDueInThirdYear Contractual Obligation, to be Paid, Year Three USD 26.88M 2025-06-30 2025 Q2 10-Q 2025-08-05 0000950170-25-103192
us-gaap ContractualObligationFutureMinimumPaymentsDueRemainderOfFiscalYear Contractual Obligation, to be Paid, Remainder of Fiscal Year USD 20.32M 2025-06-30 2025 Q2 10-Q 2025-08-05 0000950170-25-103192
us-gaap ContractWithCustomerLiability Contract with Customer, Liability USD 54.30M 2025-12-31 2025 FY 10-K 2026-02-24 0001743881-26-000009
us-gaap ContractWithCustomerLiabilityCurrent Contract with Customer, Liability, Current USD 4.74M 2026-09-30 2026 Q3 10-Q 2026-10-29 0001743881-26-000034
us-gaap ContractWithCustomerLiabilityNoncurrent Contract with Customer, Liability, Noncurrent USD 8.97M 2026-09-30 2026 Q3 10-Q 2026-10-29 0001743881-26-000034
us-gaap ContractWithCustomerRefundLiability Contract with Customer, Refund Liability USD 46.00M 2025-12-31 2025 FY 10-K 2026-02-24 0001743881-26-000009
us-gaap CostOfGoodsAndServicesSold Cost of Goods and Services Sold USD 2.73M 2021-01-01 2021-12-31 2021 FY 10-K 2022-02-25 0000950170-22-002030
us-gaap CostOfRevenue Cost of Revenue USD 45.44M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-10-29 0001743881-26-000034
us-gaap CostsAndExpenses Costs and Expenses USD 1.02B 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-10-29 0001743881-26-000034
us-gaap CurrentFederalTaxExpenseBenefit Current Federal Tax Expense (Benefit) USD -78,000 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-24 0001743881-26-000009
us-gaap CurrentForeignTaxExpenseBenefit Current Foreign Tax Expense (Benefit) USD 513,000 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-24 0001743881-26-000009
us-gaap CurrentIncomeTaxExpenseBenefit Current Income Tax Expense (Benefit) USD 435,000 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-24 0001743881-26-000009
us-gaap CurrentStateAndLocalTaxExpenseBenefit Current State and Local Tax Expense (Benefit) USD 0 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-24 0001743881-26-000009
us-gaap DebtConversionConvertedInstrumentAmount1 Debt Conversion, Converted Instrument, Amount USD 1.00M 2018-01-01 2018-12-31 2020 FY 10-K 2021-02-25 0001564590-21-008969
us-gaap DebtInstrumentCarryingAmount Long-term Debt, Gross USD 92.50M 2020-12-31 2021 FY 10-K 2022-02-25 0000950170-22-002030
us-gaap DebtInstrumentInterestRateEffectivePercentage Debt Instrument, Interest Rate, Effective Percentage pure 0.193 2024-12-31 2024 FY 10-K 2025-02-20 0000950170-25-024119
us-gaap DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet Debt Instrument, Unamortized Discount (Premium) and Debt Issuance Costs, Net USD 44.18M 2026-09-30 2026 Q3 10-Q 2026-10-29 0001743881-26-000034
us-gaap DebtIssuanceCostsIncurredDuringNoncashOrPartialNoncashTransaction Debt Issuance Costs Incurred During Noncash or Partial Noncash Transaction USD 431,000 2026-01-01 2026-03-31 2026 Q1 10-Q 2026-05-07 0001743881-26-000019
us-gaap DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger Debt Securities, Available-for-sale, Continuous Unrealized Loss Position, 12 Months or Longer USD 0 2024-06-30 2024 Q2 10-Q 2024-08-01 0000950170-24-089326
us-gaap DebtSecuritiesAvailableForSaleRealizedGainLoss Debt Securities, Available-for-sale, Realized Gain (Loss) USD 0 2024-01-01 2024-06-30 2024 Q2 10-Q 2024-08-01 0000950170-24-089326
us-gaap DeconsolidationGainOrLossAmount Deconsolidation, Gain (Loss), Amount USD 0 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-24 0001743881-26-000009
us-gaap DeferredCostsCurrentAndNoncurrent Deferred Costs USD 0 2025-12-31 2025 FY 10-K 2026-02-24 0001743881-26-000009
us-gaap DeferredFederalIncomeTaxExpenseBenefit Deferred Federal Income Tax Expense (Benefit) USD 0 2023-01-01 2023-12-31 2023 FY 10-K 2024-02-22 0000950170-24-018811
us-gaap DeferredForeignIncomeTaxExpenseBenefit Deferred Foreign Income Tax Expense (Benefit) USD 0 2023-01-01 2023-12-31 2023 FY 10-K 2024-02-22 0000950170-24-018811
us-gaap DeferredIncomeTaxExpenseBenefit Deferred Income Tax Expense (Benefit) USD 0 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-24 0001743881-26-000009
us-gaap DeferredIncomeTaxLiabilities Deferred Tax Liabilities, Gross USD 1.55M 2025-12-31 2025 FY 10-K 2026-02-24 0001743881-26-000009
us-gaap DeferredRevenueCurrent Deferred Revenue, Current USD 10.54M 2025-06-30 2025 Q2 10-Q 2025-08-05 0000950170-25-103192
us-gaap DeferredRevenueNoncurrent Deferred Revenue, Noncurrent USD 14.67M 2025-06-30 2025 Q2 10-Q 2025-08-05 0000950170-25-103192
us-gaap DeferredTaxAssetInterestCarryforward Deferred Tax Asset, Interest Carryforward USD 45.19M 2025-12-31 2025 FY 10-K 2026-02-24 0001743881-26-000009
us-gaap DeferredTaxAssetsDeferredIncome Deferred Tax Assets, Deferred Income USD 2.31M 2025-12-31 2025 FY 10-K 2026-02-24 0001743881-26-000009
us-gaap DeferredTaxAssetsEquityMethodInvestments Deferred Tax Assets, Equity Method Investments USD 16.11M 2025-12-31 2025 FY 10-K 2026-02-24 0001743881-26-000009
us-gaap DeferredTaxAssetsGross Deferred Tax Assets, Gross USD 969.57M 2025-12-31 2025 FY 10-K 2026-02-24 0001743881-26-000009
us-gaap DeferredTaxAssetsInProcessResearchAndDevelopment Deferred Tax Assets, in Process Research and Development USD 157.93M 2025-12-31 2025 FY 10-K 2026-02-24 0001743881-26-000009
us-gaap DeferredTaxAssetsLiabilitiesNet Deferred Tax Assets, Net USD 0 2025-12-31 2025 FY 10-K 2026-02-24 0001743881-26-000009
us-gaap DeferredTaxAssetsNet Deferred Tax Assets, Net of Valuation Allowance USD 1.55M 2025-12-31 2025 FY 10-K 2026-02-24 0001743881-26-000009
us-gaap DeferredTaxAssetsOperatingLossCarryforwards Deferred Tax Assets, Operating Loss Carryforwards USD 490.73M 2025-12-31 2025 FY 10-K 2026-02-24 0001743881-26-000009
us-gaap DeferredTaxAssetsOperatingLossCarryforwardsDomestic Deferred Tax Assets, Operating Loss Carryforwards, Domestic USD 1.70B 2025-12-31 2025 FY 10-K 2026-02-24 0001743881-26-000009
us-gaap DeferredTaxAssetsOperatingLossCarryforwardsForeign Deferred Tax Assets, Operating Loss Carryforwards, Foreign USD 543.00M 2025-12-31 2025 FY 10-K 2026-02-24 0001743881-26-000009
us-gaap DeferredTaxAssetsOperatingLossCarryforwardsStateAndLocal Deferred Tax Assets, Operating Loss Carryforwards, State and Local USD 462.20M 2025-12-31 2025 FY 10-K 2026-02-24 0001743881-26-000009
us-gaap DeferredTaxAssetsOther Deferred Tax Assets, Other USD 0 2025-12-31 2025 FY 10-K 2026-02-24 0001743881-26-000009
us-gaap DeferredTaxAssetsPropertyPlantAndEquipment Deferred Tax Assets, Property, Plant and Equipment USD 712,000 2025-12-31 2025 FY 10-K 2026-02-24 0001743881-26-000009
us-gaap DeferredTaxAssetsTaxCreditCarryforwards Deferred Tax Assets, Tax Credit Carryforwards USD 139.49M 2025-12-31 2025 FY 10-K 2026-02-24 0001743881-26-000009
us-gaap DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost Deferred Tax Assets, Tax Deferred Expense, Compensation and Benefits, Share-based Compensation Cost USD 20.62M 2025-12-31 2025 FY 10-K 2026-02-24 0001743881-26-000009
us-gaap DeferredTaxAssetsTaxDeferredExpenseReservesAndAccruals Deferred Tax Assets, Tax Deferred Expense, Reserves and Accruals USD 11.25M 2025-12-31 2025 FY 10-K 2026-02-24 0001743881-26-000009
us-gaap DeferredTaxAssetsUnrealizedLossesOnTradingSecurities Deferred Tax Assets, Unrealized Losses on Trading Securities USD 3.34M 2024-12-31 2024 FY 10-K 2025-02-20 0000950170-25-024119
us-gaap DeferredTaxAssetsValuationAllowance Deferred Tax Assets, Valuation Allowance USD 968.02M 2025-12-31 2025 FY 10-K 2026-02-24 0001743881-26-000009
us-gaap DeferredTaxLiabilities Deferred Tax Liabilities, Net USD 1.09M 2020-12-31 2021 FY 10-K 2022-02-25 0000950170-22-002030
us-gaap DeferredTaxLiabilitiesFinancingArrangements Deferred Tax Liabilities, Financing Arrangements USD 32.94M 2020-12-31 2021 FY 10-K 2022-02-25 0000950170-22-002030
us-gaap DeferredTaxLiabilitiesLeasingArrangements Deferred Tax Liabilities, Leasing Arrangements USD 1.47M 2025-12-31 2025 FY 10-K 2026-02-24 0001743881-26-000009
us-gaap DeferredTaxLiabilitiesOther Deferred Tax Liabilities, Other USD 86,000 2025-12-31 2025 FY 10-K 2026-02-24 0001743881-26-000009
us-gaap DeferredTaxLiabilitiesPropertyPlantAndEquipment Deferred Tax Liabilities, Property, Plant and Equipment USD 0 2023-12-31 2023 FY 10-K 2024-02-22 0000950170-24-018811
us-gaap DeferredTaxLiabilitiesUnrealizedGainsOnTradingSecurities Deferred Tax Liabilities, Unrealized Gains on Trading Securities USD 0 2024-12-31 2024 FY 10-K 2025-02-20 0000950170-25-024119
us-gaap Depreciation Depreciation USD 2.50M 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-24 0001743881-26-000009
us-gaap DepreciationAndAmortization Depreciation, Depletion and Amortization, Nonproduction USD 4.10M 2023-01-01 2023-12-31 2023 FY 10-K 2024-02-22 0000950170-24-018811
us-gaap DepreciationDepletionAndAmortization Depreciation, Depletion and Amortization USD 3.31M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-10-29 0001743881-26-000034
us-gaap DividendIncomeEquitySecuritiesOperating Dividend Income, Equity Securities, Operating USD 0 2026-01-01 2026-06-30 2026 Q2 10-Q 2026-08-10 0001743881-26-000027
us-gaap DividendsPayableCurrent Dividends Payable, Current USD 13.68M 2026-09-30 2026 Q3 10-Q 2026-10-29 0001743881-26-000034
us-gaap DueFromRelatedPartiesCurrent Due from Related Parties, Current USD 462,000 2021-09-30 2021 Q3 10-Q 2021-11-04 0000950170-21-003080
us-gaap EarningsPerShareBasic Earnings Per Share, Basic USD/shares -2.04 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-10-29 0001743881-26-000034
us-gaap EarningsPerShareBasicAndDiluted Earnings Per Share, Basic and Diluted USD/shares -1.35 2022-01-01 2022-03-31 2022 Q1 10-Q 2022-05-05 0000950170-22-007874
us-gaap EarningsPerShareDiluted Earnings Per Share, Diluted USD/shares -2.04 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-10-29 0001743881-26-000034
us-gaap EffectiveIncomeTaxRateContinuingOperations Effective Income Tax Rate Reconciliation, Percent pure -0.001 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-24 0001743881-26-000009
us-gaap EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate Effective Income Tax Rate Reconciliation, at Federal Statutory Income Tax Rate, Percent pure 0.21 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-24 0001743881-26-000009
us-gaap EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance Effective Income Tax Rate Reconciliation, Change in Deferred Tax Assets Valuation Allowance, Percent pure -0.07 2024-01-01 2024-12-31 2024 FY 10-K 2025-02-20 0000950170-25-024119
us-gaap EffectiveIncomeTaxRateReconciliationChangeInEnactedTaxRate Effective Income Tax Rate Reconciliation, Change in Enacted Tax Rate, Percent pure -0.159 2017-01-01 2017-12-31 2019 FY 10-K 2020-03-03 0001564590-20-008260
us-gaap EffectiveIncomeTaxRateReconciliationCrossBorderOtherAmount EffectiveIncomeTaxRateReconciliationCrossBorderOtherAmount USD 0 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-24 0001743881-26-000009
us-gaap EffectiveIncomeTaxRateReconciliationCrossBorderOtherPercent EffectiveIncomeTaxRateReconciliationCrossBorderOtherPercent pure 0 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-24 0001743881-26-000009
us-gaap EffectiveIncomeTaxRateReconciliationCrossBorderTaxEffectPercent EffectiveIncomeTaxRateReconciliationCrossBorderTaxEffectPercent pure -0.1 2024-01-01 2024-12-31 2024 FY 10-K 2025-02-20 0000950170-25-024119
us-gaap EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential Effective Income Tax Rate Reconciliation, Foreign Income Tax Rate Differential, Percent pure -0.056 2024-01-01 2024-12-31 2024 FY 10-K 2025-02-20 0000950170-25-024119
us-gaap EffectiveIncomeTaxRateReconciliationGiltiAmount EffectiveIncomeTaxRateReconciliationGiltiAmount USD 0 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-24 0001743881-26-000009
us-gaap EffectiveIncomeTaxRateReconciliationGiltiPercent EffectiveIncomeTaxRateReconciliationGiltiPercent pure 0 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-24 0001743881-26-000009
us-gaap EffectiveIncomeTaxRateReconciliationNondeductibleExpenseOther Effective Income Tax Rate Reconciliation, Nondeductible Expense, Other, Percent pure -0.003 2024-01-01 2024-12-31 2025 FY 10-K 2026-02-24 0001743881-26-000009
us-gaap EffectiveIncomeTaxRateReconciliationOtherAdjustments Effective Income Tax Rate Reconciliation, Other Adjustments, Percent pure -0.005 2024-01-01 2024-12-31 2024 FY 10-K 2025-02-20 0000950170-25-024119
us-gaap EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitAmount Effective Income Tax Rate Reconciliation, Tax Expense (Benefit), Share-based Payment Arrangement, Amount USD -30.85M 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-24 0001743881-26-000009
us-gaap EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitPercent Effective Income Tax Rate Reconciliation, Tax Expense (Benefit), Share-based Payment Arrangement, Percent pure 0.042 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-24 0001743881-26-000009
us-gaap EffectiveIncomeTaxRateReconciliationTaxContingencies Effective Income Tax Rate Reconciliation, Tax Contingency, Percent pure -0.007 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-24 0001743881-26-000009
us-gaap EffectiveIncomeTaxRateReconciliationTaxCreditsResearch Effective Income Tax Rate Reconciliation, Tax Credit, Research, Percent pure -0.022 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-24 0001743881-26-000009
us-gaap EffectiveIncomeTaxRateReconciliationTaxExemptIncome Effective Income Tax Rate Reconciliation, Tax Exempt Income, Percent pure 0.001 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-24 0001743881-26-000009
us-gaap EmbeddedDerivativeFairValueOfEmbeddedDerivativeLiability Embedded Derivative, Fair Value of Embedded Derivative Liability USD 14.34M 2026-09-30 2026 Q3 10-Q 2026-10-29 0001743881-26-000034
us-gaap EmbeddedDerivativeGainLossOnEmbeddedDerivativeNet Embedded Derivative, Gain (Loss) on Embedded Derivative, Net USD 7.10M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-10-29 0001743881-26-000034
us-gaap EmployeeBenefitsAndShareBasedCompensation Employee Benefits and Share-based Compensation USD 0 2020-01-01 2020-09-30 2020 Q3 10-Q 2020-11-05 0001564590-20-051460
us-gaap EmployeeRelatedLiabilitiesCurrent Employee-related Liabilities, Current USD 66.69M 2026-09-30 2026 Q3 10-Q 2026-10-29 0001743881-26-000034
us-gaap EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsCapitalizedAmount Share-based Payment Arrangement, Amount Capitalized USD 3.60M 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-24 0001743881-26-000009
us-gaap EquityMethodInvestments Equity Method Investments USD 47.78M 2026-09-30 2026 Q3 10-Q 2026-10-29 0001743881-26-000034
us-gaap EquitySecuritiesFvNi Equity Securities, FV-NI USD 0 2024-12-31 2024 FY 10-K 2025-02-20 0000950170-25-024119
us-gaap EquitySecuritiesFvNiGainLoss Equity Securities, FV-NI, Gain (Loss) USD 0 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-24 0001743881-26-000009
us-gaap EquitySecuritiesFvNiRealizedGainLoss Equity Securities, FV-NI, Realized Gain (Loss) USD 0 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-24 0001743881-26-000009
us-gaap EquitySecuritiesFvNiUnrealizedGain Equity Securities, FV-NI, Unrealized Gain USD 68.54M 2021-01-01 2021-12-31 2021 FY 10-K 2022-02-25 0000950170-22-002030
us-gaap EquitySecuritiesFvNiUnrealizedGainLoss Equity Securities, FV-NI, Unrealized Gain (Loss) USD 0 2024-01-01 2024-12-31 2025 FY 10-K 2026-02-24 0001743881-26-000009
us-gaap EquitySecuritiesFvNiUnrealizedLoss Equity Securities, FV-NI, Unrealized Loss USD 11.95M 2022-01-01 2022-12-31 2022 FY 10-K 2023-02-23 0000950170-23-004145
us-gaap FairValueAdjustmentOfWarrants Fair Value Adjustment of Warrants USD 0 2024-01-01 2024-06-30 2024 Q2 10-Q 2024-08-01 0000950170-24-089326
us-gaap FairValueOfAssetsAcquired Fair Value of Assets Acquired USD 1.92M 2018-01-01 2018-12-31 2020 FY 10-K 2021-02-25 0001564590-21-008969
us-gaap FairValueOptionChangesInFairValueGainLoss1 Fair Value, Option, Changes in Fair Value, Gain (Loss) USD -1.01M 2019-01-01 2019-09-30 2019 Q3 10-Q 2019-11-08 0001564590-19-041986
us-gaap FinanceLeaseImpairmentLoss Finance Lease, Impairment Loss USD 0 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-10-29 0001743881-26-000034
us-gaap FinanceLeaseInterestExpense Finance Lease, Interest Expense USD 29,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-10-29 0001743881-26-000034
us-gaap FinanceLeaseInterestPaymentOnLiability Finance Lease, Interest Payment on Liability USD 0 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-10-29 0001743881-26-000034
us-gaap FinanceLeaseLiability Finance Lease, Liability USD 1.54M 2021-12-31 2021 FY 10-K 2022-02-25 0000950170-22-002030
us-gaap FinanceLeaseLiabilityCurrent Finance Lease, Liability, Current USD 295,000 2021-12-31 2021 FY 10-K 2022-02-25 0000950170-22-002030
us-gaap FinanceLeaseLiabilityNoncurrent Finance Lease, Liability, Noncurrent USD 1.25M 2021-12-31 2021 FY 10-K 2022-02-25 0000950170-22-002030
us-gaap FinanceLeaseLiabilityPaymentsDue Finance Lease, Liability, Payment, Due USD 1.76M 2021-12-31 2021 FY 10-K 2022-02-25 0000950170-22-002030
us-gaap FinanceLeaseLiabilityPaymentsDueAfterYearFive Finance Lease, Liability, to be Paid, after Year Five USD 0 2021-12-31 2021 FY 10-K 2022-02-25 0000950170-22-002030
us-gaap FinanceLeaseLiabilityPaymentsDueNextTwelveMonths Finance Lease, Liability, to be Paid, Year One USD 387,000 2021-12-31 2021 FY 10-K 2022-02-25 0000950170-22-002030
us-gaap FinanceLeaseLiabilityPaymentsDueYearFive Finance Lease, Liability, to be Paid, Year Five USD 38,000 2021-12-31 2021 FY 10-K 2022-02-25 0000950170-22-002030
us-gaap FinanceLeaseLiabilityPaymentsDueYearFour Finance Lease, Liability, to be Paid, Year Four USD 459,000 2021-12-31 2021 FY 10-K 2022-02-25 0000950170-22-002030
us-gaap FinanceLeaseLiabilityPaymentsDueYearThree Finance Lease, Liability, to be Paid, Year Three USD 445,000 2021-12-31 2021 FY 10-K 2022-02-25 0000950170-22-002030
us-gaap FinanceLeaseLiabilityPaymentsDueYearTwo Finance Lease, Liability, to be Paid, Year Two USD 432,000 2021-12-31 2021 FY 10-K 2022-02-25 0000950170-22-002030
us-gaap FinanceLeaseLiabilityPaymentsRemainderOfFiscalYear Finance Lease, Liability, to be Paid, Remainder of Fiscal Year USD 66,000 2021-09-30 2021 Q3 10-Q 2021-11-04 0000950170-21-003080
us-gaap FinanceLeaseLiabilityUndiscountedExcessAmount Finance Lease, Liability, Undiscounted Excess Amount USD 221,000 2021-12-31 2021 FY 10-K 2022-02-25 0000950170-22-002030
us-gaap FinanceLeasePrincipalPayments Finance Lease, Principal Payments USD 71,000 2021-01-01 2021-09-30 2021 Q3 10-Q 2021-11-04 0000950170-21-003080
us-gaap FinanceLeaseWeightedAverageDiscountRatePercent Finance Lease, Weighted Average Discount Rate, Percent pure 0.066 2025-12-31 2025 FY 10-K 2026-02-24 0001743881-26-000009
us-gaap FiniteLivedIntangibleAssetsAccumulatedAmortization Finite-Lived Intangible Assets, Accumulated Amortization USD 13.48M 2026-09-30 2026 Q3 10-Q 2026-10-29 0001743881-26-000034
us-gaap FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive Finite-Lived Intangible Asset, Expected Amortization, after Year Five USD 10.70M 2026-09-30 2026 Q3 10-Q 2026-10-29 0001743881-26-000034
us-gaap FiniteLivedIntangibleAssetsAmortizationExpenseNextRollingTwelveMonths Finite-Lived Intangible Assets, Amortization Expense, Next Rolling Twelve Months USD 2.90M 2025-06-30 2025 Q2 10-Q 2025-08-05 0000950170-25-103192
us-gaap FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths Finite-Lived Intangible Asset, Expected Amortization, Year One USD 2.90M 2026-09-30 2026 Q3 10-Q 2026-10-29 0001743881-26-000034
us-gaap FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear Finite-Lived Intangible Asset, Expected Amortization, Remainder of Fiscal Year USD 700,000 2026-09-30 2026 Q3 10-Q 2026-10-29 0001743881-26-000034
us-gaap FiniteLivedIntangibleAssetsAmortizationExpenseRollingAfterYearFive Finite-Lived Intangible Assets, Amortization Expense, Rolling after Year Five USD 13.60M 2025-06-30 2025 Q2 10-Q 2025-08-05 0000950170-25-103192
us-gaap FiniteLivedIntangibleAssetsAmortizationExpenseRollingYearFive Finite-Lived Intangible Assets, Amortization Expense, Rolling Year Five USD 2.90M 2025-06-30 2025 Q2 10-Q 2025-08-05 0000950170-25-103192
us-gaap FiniteLivedIntangibleAssetsAmortizationExpenseRollingYearFour Finite-Lived Intangible Assets, Amortization Expense, Rolling Year Four USD 2.90M 2025-06-30 2025 Q2 10-Q 2025-08-05 0000950170-25-103192
us-gaap FiniteLivedIntangibleAssetsAmortizationExpenseRollingYearThree Finite-Lived Intangible Assets, Amortization Expense, Rolling Year Three USD 2.90M 2025-06-30 2025 Q2 10-Q 2025-08-05 0000950170-25-103192
us-gaap FiniteLivedIntangibleAssetsAmortizationExpenseRollingYearTwo Finite-Lived Intangible Assets, Amortization Expense, Rolling Year Two USD 2.90M 2025-06-30 2025 Q2 10-Q 2025-08-05 0000950170-25-103192
us-gaap FiniteLivedIntangibleAssetsAmortizationExpenseYearFive Finite-Lived Intangible Asset, Expected Amortization, Year Five USD 2.90M 2026-09-30 2026 Q3 10-Q 2026-10-29 0001743881-26-000034
us-gaap FiniteLivedIntangibleAssetsAmortizationExpenseYearFour Finite-Lived Intangible Asset, Expected Amortization, Year Four USD 2.90M 2026-09-30 2026 Q3 10-Q 2026-10-29 0001743881-26-000034
us-gaap FiniteLivedIntangibleAssetsAmortizationExpenseYearThree Finite-Lived Intangible Asset, Expected Amortization, Year Three USD 2.90M 2026-09-30 2026 Q3 10-Q 2026-10-29 0001743881-26-000034
us-gaap FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo Finite-Lived Intangible Asset, Expected Amortization, Year Two USD 2.90M 2026-09-30 2026 Q3 10-Q 2026-10-29 0001743881-26-000034
us-gaap FiniteLivedIntangibleAssetsGross Finite-Lived Intangible Assets, Gross USD 39.40M 2026-09-30 2026 Q3 10-Q 2026-10-29 0001743881-26-000034
us-gaap FiniteLivedIntangibleAssetsNet Finite-Lived Intangible Assets, Net USD 25.92M 2026-09-30 2026 Q3 10-Q 2026-10-29 0001743881-26-000034
us-gaap GainLossOnDispositionOfAssets1 Gain (Loss) on Disposition of Assets USD 0 2024-01-01 2024-12-31 2024 FY 10-K 2025-02-20 0000950170-25-024119
us-gaap GainLossOnSaleOfPropertyPlantEquipment Gain (Loss) on Disposition of Property Plant Equipment USD -63,000 2019-01-01 2019-09-30 2019 Q3 10-Q 2019-11-08 0001564590-19-041986
us-gaap GainsLossesOnExtinguishmentOfDebt Gain (Loss) on Extinguishment of Debt USD 0 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-10-29 0001743881-26-000034
us-gaap GeneralAndAdministrativeExpense General and Administrative Expense USD 45.41M 2021-01-01 2021-03-31 2021 Q1 10-Q 2021-05-06 0001564590-21-025064
us-gaap ImpairmentOfLongLivedAssetsHeldForUse Impairment of Long-Lived Assets Held-for-use USD 0 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-24 0001743881-26-000009
us-gaap IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic Income (Loss) from Continuing Operations before Income Taxes, Domestic USD -437.61M 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-24 0001743881-26-000009
us-gaap IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest USD -381.71M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-10-29 0001743881-26-000034
us-gaap IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign Income (Loss) from Continuing Operations before Income Taxes, Foreign USD -294.89M 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-24 0001743881-26-000009
us-gaap IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments Income (Loss) from Continuing Operations before Equity Method Investments, Income Taxes, Noncontrolling Interest USD 505.49M 2020-01-01 2020-12-31 2020 FY 10-K 2021-02-25 0001564590-21-008969
us-gaap IncomeLossFromEquityMethodInvestments Income (Loss) from Equity Method Investments USD -32.03M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-10-29 0001743881-26-000034
us-gaap IncomeTaxesPaid Income Taxes Paid USD 1.20M 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-24 0001743881-26-000009
us-gaap IncomeTaxesPaidNet Income Taxes Paid, Net USD 1.20M 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-24 0001743881-26-000009
us-gaap IncomeTaxExpenseBenefit Income Tax Expense (Benefit) USD 1.23M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-10-29 0001743881-26-000034
us-gaap IncomeTaxPaidFederalAfterRefundReceived IncomeTaxPaidFederalAfterRefundReceived USD 1.00M 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-24 0001743881-26-000009
us-gaap IncomeTaxPaidForeignAfterRefundReceived IncomeTaxPaidForeignAfterRefundReceived USD 198,000 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-24 0001743881-26-000009
us-gaap IncomeTaxPaidStateAndLocalAfterRefundReceived IncomeTaxPaidStateAndLocalAfterRefundReceived USD 0 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-24 0001743881-26-000009
us-gaap IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate Effective Income Tax Rate Reconciliation at Federal Statutory Income Tax Rate, Amount USD -153.83M 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-24 0001743881-26-000009
us-gaap IncomeTaxReconciliationNondeductibleExpenseOther Effective Income Tax Rate Reconciliation, Nondeductible Expense, Other, Amount USD 1.69M 2024-01-01 2024-12-31 2025 FY 10-K 2026-02-24 0001743881-26-000009
us-gaap IncomeTaxReconciliationTaxContingencies Effective Income Tax Rate Reconciliation, Tax Contingency, Amount USD 4.98M 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-24 0001743881-26-000009
us-gaap IncomeTaxReconciliationTaxCreditsResearch Effective Income Tax Rate Reconciliation, Tax Credit, Research, Amount USD 15.88M 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-24 0001743881-26-000009
us-gaap IncomeTaxReconciliationTaxExemptIncome Effective Income Tax Rate Reconciliation, Tax Exempt Income, Amount USD -555,000 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-24 0001743881-26-000009
us-gaap IncreaseDecreaseInAccountsPayable Increase (Decrease) in Accounts Payable USD 51.99M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-10-29 0001743881-26-000034
us-gaap IncreaseDecreaseInAccountsReceivable Increase (Decrease) in Accounts Receivable USD 235.65M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-10-29 0001743881-26-000034
us-gaap IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities Increase (Decrease) in Accrued Liabilities and Other Operating Liabilities USD 4.19M 2024-01-01 2024-12-31 2024 FY 10-K 2025-02-20 0000950170-25-024119
us-gaap IncreaseDecreaseInContractWithCustomerLiability Increase (Decrease) in Contract with Customer, Liability USD 150.10M 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-24 0001743881-26-000009
us-gaap IncreaseDecreaseInDeferredRevenue Increase (Decrease) in Deferred Revenue USD -6.56M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-10-29 0001743881-26-000034
us-gaap IncreaseDecreaseInDueFromRelatedParties Increase (Decrease) in Due from Related Parties USD 0 2022-01-01 2022-12-31 2022 FY 10-K 2023-02-23 0000950170-23-004145
us-gaap IncreaseDecreaseInEmployeeRelatedLiabilities Increase (Decrease) in Employee Related Liabilities USD -9.05M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-10-29 0001743881-26-000034
us-gaap IncreaseDecreaseInInventories Increase (Decrease) in Inventories USD 35.64M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-10-29 0001743881-26-000034
us-gaap IncreaseDecreaseInOperatingLeaseLiability IncreaseDecreaseInOperatingLeaseLiability USD -5.49M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-10-29 0001743881-26-000034
us-gaap IncreaseDecreaseInOtherCurrentLiabilities Increase (Decrease) in Other Current Liabilities USD 26.61M 2025-01-01 2025-06-30 2025 Q2 10-Q 2025-08-05 0000950170-25-103192
us-gaap IncreaseDecreaseInOtherOperatingAssets Increase (Decrease) in Other Operating Assets USD 5.85M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-10-29 0001743881-26-000034
us-gaap IncreaseDecreaseInOtherOperatingLiabilities Increase (Decrease) in Other Operating Liabilities USD 48.40M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-10-29 0001743881-26-000034
us-gaap IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets Increase (Decrease) in Prepaid Expense and Other Assets USD 26.87M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-10-29 0001743881-26-000034
us-gaap IntangibleAssetsNetExcludingGoodwill Intangible Assets, Net (Excluding Goodwill) USD 25.92M 2026-09-30 2026 Q3 10-Q 2026-10-29 0001743881-26-000034
us-gaap IntangibleAssetsNetIncludingGoodwill Intangible Assets, Net (Including Goodwill) USD 20.00M 2021-06-30 2021 Q2 10-Q 2021-08-05 0001564590-21-041676
us-gaap InterestExpense Interest Expense USD 46.41M 2024-01-01 2024-06-30 2024 Q2 10-Q 2024-08-01 0000950170-24-089326
us-gaap InterestExpenseDebt Interest Expense, Debt USD 21.19M 2025-01-01 2025-06-30 2025 Q2 10-Q 2025-08-05 0000950170-25-103192
us-gaap InterestExpenseDebtExcludingAmortization Interest Expense, Debt, Excluding Amortization USD 18.64M 2025-01-01 2025-06-30 2025 Q2 10-Q 2025-08-05 0000950170-25-103192
us-gaap InterestExpenseNonoperating InterestExpenseNonoperating USD 39.48M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-10-29 0001743881-26-000034
us-gaap InterestPaidNet Interest Paid, Excluding Capitalized Interest, Operating Activities USD 43.13M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-10-29 0001743881-26-000034
us-gaap InterestPayableCurrent Interest Payable, Current USD 5.04M 2026-09-30 2026 Q3 10-Q 2026-10-29 0001743881-26-000034
us-gaap InventoryFinishedGoods Inventory, Finished Goods, Gross USD 17.64M 2026-09-30 2026 Q3 10-Q 2026-10-29 0001743881-26-000034
us-gaap InventoryNet Inventory, Net USD 59.72M 2026-09-30 2026 Q3 10-Q 2026-10-29 0001743881-26-000034
us-gaap InventoryRawMaterials Inventory, Raw Materials, Gross USD 30.00M 2026-09-30 2026 Q3 10-Q 2026-10-29 0001743881-26-000034
us-gaap InventoryValuationReserves Inventory Valuation Reserves USD 3.95M 2026-09-30 2026 Q3 10-Q 2026-10-29 0001743881-26-000034
us-gaap InventoryWorkInProcess Inventory, Work in Process, Gross USD 16.02M 2026-09-30 2026 Q3 10-Q 2026-10-29 0001743881-26-000034
us-gaap InvestmentIncomeInterest Investment Income, Interest USD 26.01M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-10-29 0001743881-26-000034
us-gaap InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures Investments in and Advance to Affiliates, Subsidiaries, Associates, and Joint Ventures USD 92.17M 2025-09-30 2025 Q3 10-Q 2025-10-29 0001743881-25-000012
us-gaap LeaseAndRentalExpense Operating Leases, Rent Expense USD 2.80M 2019-01-01 2019-12-31 2020 FY 10-K 2021-02-25 0001564590-21-008969
us-gaap LeaseCost Lease, Cost USD 7.43M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-10-29 0001743881-26-000034
us-gaap LesseeOperatingLeaseLiabilityPaymentsDue Lessee, Operating Lease, Liability, to be Paid USD 20.98M 2026-09-30 2026 Q3 10-Q 2026-10-29 0001743881-26-000034
us-gaap LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive Lessee, Operating Lease, Liability, to be Paid, after Year Five USD 4.67M 2026-09-30 2026 Q3 10-Q 2026-10-29 0001743881-26-000034
us-gaap LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths Lessee, Operating Lease, Liability, to be Paid, Year One USD 2.42M 2026-09-30 2026 Q3 10-Q 2026-10-29 0001743881-26-000034
us-gaap LesseeOperatingLeaseLiabilityPaymentsDueYearFive Lessee, Operating Lease, Liability, to be Paid, Year Five USD 3.03M 2026-09-30 2026 Q3 10-Q 2026-10-29 0001743881-26-000034
us-gaap LesseeOperatingLeaseLiabilityPaymentsDueYearFour Lessee, Operating Lease, Liability, to be Paid, Year Four USD 3.18M 2026-09-30 2026 Q3 10-Q 2026-10-29 0001743881-26-000034
us-gaap LesseeOperatingLeaseLiabilityPaymentsDueYearThree Lessee, Operating Lease, Liability, to be Paid, Year Three USD 3.11M 2026-09-30 2026 Q3 10-Q 2026-10-29 0001743881-26-000034
us-gaap LesseeOperatingLeaseLiabilityPaymentsDueYearTwo Lessee, Operating Lease, Liability, to be Paid, Year Two USD 3.49M 2026-09-30 2026 Q3 10-Q 2026-10-29 0001743881-26-000034
us-gaap LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear Lessee, Operating Lease, Liability, to be Paid, Remainder of Fiscal Year USD 1.07M 2026-09-30 2026 Q3 10-Q 2026-10-29 0001743881-26-000034
us-gaap LesseeOperatingLeaseLiabilityUndiscountedExcessAmount Lessee, Operating Lease, Liability, Undiscounted Excess Amount USD 4.35M 2026-09-30 2026 Q3 10-Q 2026-10-29 0001743881-26-000034
us-gaap Liabilities Liabilities USD 3.82B 2026-09-30 2026 Q3 10-Q 2026-10-29 0001743881-26-000034
us-gaap LiabilitiesAndStockholdersEquity Liabilities and Equity USD 2.16B 2026-09-30 2026 Q3 10-Q 2026-10-29 0001743881-26-000034
us-gaap LiabilitiesCurrent Liabilities, Current USD 977.24M 2026-09-30 2026 Q3 10-Q 2026-10-29 0001743881-26-000034
us-gaap LongTermDebt Long-term Debt USD 2.63B 2026-09-30 2026 Q3 10-Q 2026-10-29 0001743881-26-000034
us-gaap LongTermDebtCurrent Long-term Debt, Current Maturities USD 1.46M 2020-12-31 2021 FY 10-K 2022-02-25 0000950170-22-002030
us-gaap LongTermDebtMaturitiesRepaymentsOfPrincipalAfterYearFive Long-Term Debt, Maturity, after Year Five USD 639.63M 2026-09-30 2026 Q3 10-Q 2026-10-29 0001743881-26-000034
us-gaap LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths Long-Term Debt, Maturity, Year One USD 588.50M 2026-09-30 2026 Q3 10-Q 2026-10-29 0001743881-26-000034
us-gaap LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive Long-Term Debt, Maturity, Year Five USD 584.77M 2026-09-30 2026 Q3 10-Q 2026-10-29 0001743881-26-000034
us-gaap LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour Long-Term Debt, Maturity, Year Four USD 14.81M 2026-09-30 2026 Q3 10-Q 2026-10-29 0001743881-26-000034
us-gaap LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree Long-Term Debt, Maturity, Year Three USD 770.72M 2026-09-30 2026 Q3 10-Q 2026-10-29 0001743881-26-000034
us-gaap LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo Long-Term Debt, Maturity, Year Two USD 31.63M 2026-09-30 2026 Q3 10-Q 2026-10-29 0001743881-26-000034
us-gaap LongTermDebtMaturitiesRepaymentsOfPrincipalRemainderOfFiscalYear Long-Term Debt, Maturity, Remainder of Fiscal Year USD 22.83M 2026-06-30 2026 Q2 10-Q 2026-08-10 0001743881-26-000027
us-gaap LongTermDebtNoncurrent Long-term Debt, Excluding Current Maturities USD 0 2025-06-30 2025 Q2 10-Q 2025-08-05 0000950170-25-103192
us-gaap LongTermLoansPayable Loans Payable, Noncurrent USD 422.97M 2022-09-30 2022 Q3 10-Q 2022-11-03 0000950170-22-021936
us-gaap MarketableSecurities Marketable Securities USD 0 2024-12-31 2025 Q2 10-Q 2025-08-05 0000950170-25-103192
us-gaap MarketableSecuritiesCurrent Marketable Securities, Current USD 7.94M 2025-06-30 2025 Q2 10-Q 2025-08-05 0000950170-25-103192
us-gaap MarketableSecuritiesNoncurrent Marketable Securities, Noncurrent USD 60.69M 2021-06-30 2021 Q2 10-Q 2021-08-05 0001564590-21-041676
us-gaap MinorityInterest Stockholders' Equity Attributable to Noncontrolling Interest USD 10.20M 2026-09-30 2026 Q3 10-Q 2026-10-29 0001743881-26-000034
us-gaap MinorityInterestDecreaseFromRedemptions Noncontrolling Interest, Decrease from Redemptions or Purchase of Interests USD -92.00M 2021-01-01 2021-12-31 2023 FY 10-K 2024-02-22 0000950170-24-018811
us-gaap MinorityInterestPeriodIncreaseDecrease Noncontrolling Interest, Period Increase (Decrease) USD -2.50M 2026-07-01 2026-09-30 2026 Q3 10-Q 2026-10-29 0001743881-26-000034
us-gaap MoneyMarketFundsAtCarryingValue Money Market Funds, at Carrying Value USD 395,800 2018-12-31 2019 FY 10-K 2020-03-03 0001564590-20-008260
us-gaap NetCashProvidedByUsedInFinancingActivities Net Cash Provided by (Used in) Financing Activities USD 1.26B 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-10-29 0001743881-26-000034
us-gaap NetCashProvidedByUsedInInvestingActivities Net Cash Provided by (Used in) Investing Activities USD 11.76M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-10-29 0001743881-26-000034
us-gaap NetCashProvidedByUsedInOperatingActivities Net Cash Provided by (Used in) Operating Activities USD -312.55M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-10-29 0001743881-26-000034
us-gaap NetIncomeLoss Net Income (Loss) Attributable to Parent USD -372.97M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-10-29 0001743881-26-000034
us-gaap NetIncomeLossAttributableToNoncontrollingInterest Net Income (Loss) Attributable to Noncontrolling Interest USD -9.97M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-10-29 0001743881-26-000034
us-gaap NetIncomeLossAttributableToNonredeemableNoncontrollingInterest Net Income (Loss) Attributable to Nonredeemable Noncontrolling Interest USD -13.18M 2020-07-01 2020-09-30 2020 Q3 10-Q 2020-11-05 0001564590-20-051460
us-gaap NetIncomeLossAvailableToCommonStockholdersBasic Net Income (Loss) Available to Common Stockholders, Basic USD -399.26M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-10-29 0001743881-26-000034
us-gaap NoncontrollingInterestDecreaseFromDeconsolidation Noncontrolling Interest, Decrease from Deconsolidation USD 179.04M 2024-01-01 2024-12-31 2024 FY 10-K 2025-02-20 0000950170-25-024119
us-gaap NoncontrollingInterestIncreaseFromSubsidiaryEquityIssuance Noncontrolling Interest, Increase from Subsidiary Equity Issuance USD 164,000 2024-04-01 2024-06-30 2025 Q3 10-Q 2025-10-29 0001743881-25-000012
us-gaap NonoperatingIncomeExpense Nonoperating Income (Expense) USD -157.04M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-10-29 0001743881-26-000034
us-gaap NumberOfOperatingSegments Number of Operating Segments segment 1 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-10-29 0001743881-26-000034
us-gaap NumberOfReportableSegments Number of Reportable Segments segment 1 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-10-29 0001743881-26-000034
us-gaap OperatingExpenses Operating Expenses USD 167.97M 2021-01-01 2021-03-31 2021 Q1 10-Q 2021-05-06 0001564590-21-025064
us-gaap OperatingIncomeLoss Operating Income (Loss) USD -224.67M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-10-29 0001743881-26-000034
us-gaap OperatingLeaseCost Operating Lease, Cost USD 4.71M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-10-29 0001743881-26-000034
us-gaap OperatingLeaseImpairmentLoss Operating Lease, Impairment Loss USD 0 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-10-29 0001743881-26-000034
us-gaap OperatingLeaseLiability Operating Lease, Liability USD 16.63M 2026-09-30 2026 Q3 10-Q 2026-10-29 0001743881-26-000034
us-gaap OperatingLeaseLiabilityCurrent Operating Lease, Liability, Current USD 1.99M 2026-09-30 2026 Q3 10-Q 2026-10-29 0001743881-26-000034
us-gaap OperatingLeaseLiabilityNoncurrent Operating Lease, Liability, Noncurrent USD 14.64M 2026-09-30 2026 Q3 10-Q 2026-10-29 0001743881-26-000034
us-gaap OperatingLeasePayments Operating Lease, Payments USD 5.49M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-10-29 0001743881-26-000034
us-gaap OperatingLeaseRightOfUseAsset Operating Lease, Right-of-Use Asset USD 15.75M 2026-09-30 2026 Q3 10-Q 2026-10-29 0001743881-26-000034
us-gaap OperatingLeaseRightOfUseAssetAmortizationExpense Operating Lease, Right-of-Use Asset, Amortization Expense USD 4.71M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-10-29 0001743881-26-000034
us-gaap OperatingLeasesFutureMinimumPaymentsDue Operating Leases, Future Minimum Payments Due USD 11.71M 2019-12-31 2020 FY 10-K 2021-02-25 0001564590-21-008969
us-gaap OperatingLeasesFutureMinimumPaymentsDueCurrent Operating Leases, Future Minimum Payments Due, Next Twelve Months USD 2.81M 2019-12-31 2020 FY 10-K 2021-02-25 0001564590-21-008969
us-gaap OperatingLeasesFutureMinimumPaymentsDueInFiveYears Operating Leases, Future Minimum Payments, Due in Five Years USD 1.27M 2019-12-31 2020 FY 10-K 2021-02-25 0001564590-21-008969
us-gaap OperatingLeasesFutureMinimumPaymentsDueInFourYears Operating Leases, Future Minimum Payments, Due in Four Years USD 1.49M 2019-12-31 2020 FY 10-K 2021-02-25 0001564590-21-008969
us-gaap OperatingLeasesFutureMinimumPaymentsDueInThreeYears Operating Leases, Future Minimum Payments, Due in Three Years USD 1.81M 2019-12-31 2020 FY 10-K 2021-02-25 0001564590-21-008969
us-gaap OperatingLeasesFutureMinimumPaymentsDueInTwoYears Operating Leases, Future Minimum Payments, Due in Two Years USD 2.52M 2019-12-31 2020 FY 10-K 2021-02-25 0001564590-21-008969
us-gaap OperatingLeasesFutureMinimumPaymentsDueThereafter Operating Leases, Future Minimum Payments, Due Thereafter USD 1.82M 2019-12-31 2020 FY 10-K 2021-02-25 0001564590-21-008969
us-gaap OperatingLeasesFutureMinimumPaymentsRemainderOfFiscalYear Operating Leases, Future Minimum Payments, Remainder of Fiscal Year USD 542,000 2019-09-30 2019 Q3 10-Q 2019-11-08 0001564590-19-041986
us-gaap OperatingLeasesRentExpenseNet Operating Leases, Rent Expense, Net USD 2.20M 2017-03-01 2017-03-31 2019 FY 10-K 2020-03-03 0001564590-20-008260
us-gaap OperatingLeaseWeightedAverageDiscountRatePercent Operating Lease, Weighted Average Discount Rate, Percent pure 0.068 2025-12-31 2025 FY 10-K 2026-02-24 0001743881-26-000009
us-gaap OtherAccruedLiabilitiesCurrent Other Accrued Liabilities, Current USD 11.84M 2026-09-30 2026 Q3 10-Q 2026-10-29 0001743881-26-000034
us-gaap OtherAssetsCurrent Other Assets, Current USD 13.35M 2019-09-30 2019 Q3 10-Q 2019-11-08 0001564590-19-041986
us-gaap OtherAssetsNoncurrent Other Assets, Noncurrent USD 22.69M 2026-09-30 2026 Q3 10-Q 2026-10-29 0001743881-26-000034
us-gaap OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax OCI, Debt Securities, Available-for-Sale, Unrealized Holding Gain (Loss), before Adjustment, after Tax USD -107,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-10-29 0001743881-26-000034
us-gaap OtherLiabilitiesCurrent Other Liabilities, Current USD 212.11M 2026-09-30 2026 Q3 10-Q 2026-10-29 0001743881-26-000034
us-gaap OtherLiabilitiesNoncurrent Other Liabilities, Noncurrent USD 1.41M 2026-09-30 2026 Q3 10-Q 2026-10-29 0001743881-26-000034
us-gaap OtherNoncashIncomeExpense Other Noncash Income (Expense) USD -2.23M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-10-29 0001743881-26-000034
us-gaap OtherNonoperatingExpense Other Nonoperating Expense USD 1.21M 2019-01-01 2019-12-31 2019 FY 10-K 2020-03-03 0001564590-20-008260
us-gaap OtherNonoperatingIncomeExpense Other Nonoperating Income (Expense) USD 11.96M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-10-29 0001743881-26-000034
us-gaap OtherPreferredStockDividendsAndAdjustments Other Preferred Stock Dividends and Adjustments USD 26.29M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-10-29 0001743881-26-000034
us-gaap PaidInKindInterest Paid-in-Kind Interest USD 0 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-24 0001743881-26-000009
us-gaap PaymentsForProceedsFromOtherInvestingActivities Payments for (Proceeds from) Other Investing Activities USD 0 2022-01-01 2022-12-31 2022 FY 10-K 2023-02-23 0000950170-23-004145
us-gaap PaymentsForRepurchaseOfCommonStock Payments for Repurchase of Common Stock USD 252.50M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-10-29 0001743881-26-000034
us-gaap PaymentsForRepurchaseOfRedeemableNoncontrollingInterest Payments for Repurchase of Redeemable Noncontrolling Interest USD 28.63M 2019-01-01 2019-06-30 2020 Q2 10-Q 2020-08-11 0001564590-20-039358
us-gaap PaymentsForRestructuring Payments for Restructuring USD 14.48M 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-24 0001743881-26-000009
us-gaap PaymentsForTenantImprovements Payments for Tenant Improvements USD 0 2023-01-01 2023-12-31 2023 FY 10-K 2024-02-22 0000950170-24-018811
us-gaap PaymentsOfCapitalDistribution Payments of Capital Distribution USD 997,000 2019-01-01 2019-12-31 2020 FY 10-K 2021-02-25 0001564590-21-008969
us-gaap PaymentsOfDebtIssuanceCosts Payments of Debt Issuance Costs USD 15.99M 2024-01-01 2024-12-31 2024 FY 10-K 2025-02-20 0000950170-25-024119
us-gaap PaymentsOfDividends Payments of Dividends USD 997,000 2019-01-01 2019-09-30 2020 Q3 10-Q 2020-11-05 0001564590-20-051460
us-gaap PaymentsOfDividendsPreferredStockAndPreferenceStock Payments of Ordinary Dividends, Preferred Stock and Preference Stock USD 2.69M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-10-29 0001743881-26-000034
us-gaap PaymentsOfFinancingCosts Payments of Financing Costs USD 0 2023-01-01 2023-09-30 2023 Q3 10-Q 2023-11-02 0000950170-23-058255
us-gaap PaymentsOfStockIssuanceCosts Payments of Stock Issuance Costs USD 1.34M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-10-29 0001743881-26-000034
us-gaap PaymentsRelatedToTaxWithholdingForShareBasedCompensation Payment, Tax Withholding, Share-based Payment Arrangement USD 13.43M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-10-29 0001743881-26-000034
us-gaap PaymentsToAcquireAvailableForSaleSecuritiesDebt Payments to Acquire Debt Securities, Available-for-sale USD 63.94M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-10-29 0001743881-26-000034
us-gaap PaymentsToAcquireEquityMethodInvestments Payments to Acquire Equity Method Investments USD 53.38M 2021-01-01 2021-12-31 2021 FY 10-K 2022-02-25 0000950170-22-002030
us-gaap PaymentsToAcquireEquitySecuritiesFvNi PaymentsToAcquireEquitySecuritiesFvNi USD 0 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-24 0001743881-26-000009
us-gaap PaymentsToAcquireInProcessResearchAndDevelopment Payments to Acquire in Process Research and Development USD 2.50M 2019-01-01 2019-12-31 2020 FY 10-K 2021-02-25 0001564590-21-008969
us-gaap PaymentsToAcquireIntangibleAssets Payments to Acquire Intangible Assets USD 0 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-10-29 0001743881-26-000034
us-gaap PaymentsToAcquireMarketableSecurities Payments to Acquire Marketable Securities USD 7.91M 2025-01-01 2025-06-30 2025 Q2 10-Q 2025-08-05 0000950170-25-103192
us-gaap PaymentsToAcquirePropertyPlantAndEquipment Payments to Acquire Property, Plant, and Equipment USD 802,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-10-29 0001743881-26-000034
us-gaap PaymentsToMinorityShareholders Payments to Noncontrolling Interests USD 0 2022-01-01 2022-12-31 2022 FY 10-K 2023-02-23 0000950170-23-004145
us-gaap PreferredStockAccretionOfRedemptionDiscount Preferred Stock, Accretion of Redemption Discount USD 0 2026-07-01 2026-09-30 2026 Q3 10-Q 2026-10-29 0001743881-26-000034
us-gaap PreferredStockDividendsAndOtherAdjustments Preferred Stock Dividends and Other Adjustments USD 26.29M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-10-29 0001743881-26-000034
us-gaap PreferredStockParOrStatedValuePerShare Preferred Stock, Par or Stated Value Per Share USD/shares 0.001 2026-06-30 2026 Q2 10-Q 2026-08-10 0001743881-26-000027
us-gaap PreferredStockSharesAuthorized Preferred Stock, Shares Authorized shares 25.00M 2026-06-30 2026 Q2 10-Q 2026-08-10 0001743881-26-000027
us-gaap PreferredStockSharesIssued Preferred Stock, Shares Issued shares 0 2026-06-30 2026 Q2 10-Q 2026-08-10 0001743881-26-000027
us-gaap PreferredStockSharesOutstanding Preferred Stock, Shares Outstanding shares 0 2026-06-30 2026 Q2 10-Q 2026-08-10 0001743881-26-000027
us-gaap PreferredStockValue Preferred Stock, Value, Issued USD 0 2026-06-30 2026 Q2 10-Q 2026-08-10 0001743881-26-000027
us-gaap PrepaidExpenseAndOtherAssetsCurrent Prepaid Expense and Other Assets, Current USD 70.94M 2026-09-30 2026 Q3 10-Q 2026-10-29 0001743881-26-000034
us-gaap PrepaidExpenseCurrent Prepaid Expense, Current USD 8.75M 2019-09-30 2019 Q3 10-Q 2019-11-08 0001564590-19-041986
us-gaap ProceedsFromConvertibleDebt Proceeds from Convertible Debt USD 0 2023-01-01 2023-12-31 2023 FY 10-K 2024-02-22 0000950170-24-018811
us-gaap ProceedsFromDebtNetOfIssuanceCosts Proceeds from Debt, Net of Issuance Costs USD 450.00M 2024-01-01 2024-12-31 2024 FY 10-K 2025-02-20 0000950170-25-024119
us-gaap ProceedsFromEquityMethodInvestmentDividendsOrDistributionsReturnOfCapital Proceeds from Equity Method Investment, Distribution, Return of Capital USD 0 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-10-29 0001743881-26-000034
us-gaap ProceedsFromIssuanceInitialPublicOffering Proceeds from Issuance Initial Public Offering USD 366.24M 2019-01-01 2019-12-31 2021 FY 10-K 2022-02-25 0000950170-22-002030
us-gaap ProceedsFromIssuanceOfCommonStock Proceeds from Issuance of Common Stock USD 0 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-24 0001743881-26-000009
us-gaap ProceedsFromIssuanceOfDebt Proceeds from Issuance of Debt USD 1.00M 2018-01-01 2018-12-31 2020 FY 10-K 2021-02-25 0001564590-21-008969
us-gaap ProceedsFromIssuanceOfLongTermDebt Proceeds from Issuance of Long-term Debt USD 450.00M 2024-01-01 2024-09-30 2024 Q3 10-Q 2024-11-12 0000950170-24-124577
us-gaap ProceedsFromIssuanceOfPreferredStockAndPreferenceStock Proceeds from Issuance of Preferred Stock and Preference Stock USD 933.90M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-10-29 0001743881-26-000034
us-gaap ProceedsFromIssuanceOfPrivatePlacement Proceeds from Issuance of Private Placement USD 240.80M 2023-01-01 2023-12-31 2023 FY 10-K 2024-02-22 0000950170-24-018811
us-gaap ProceedsFromIssuanceOfRedeemableConvertiblePreferredStock Proceeds from Issuance of Redeemable Convertible Preferred Stock USD 335.00M 2018-01-01 2018-12-31 2020 FY 10-K 2021-02-25 0001564590-21-008969
us-gaap ProceedsFromMinorityShareholders Proceeds from Noncontrolling Interests USD 0 2022-01-01 2022-12-31 2022 FY 10-K 2023-02-23 0000950170-23-004145
us-gaap ProceedsFromPaymentsForOtherFinancingActivities Proceeds from (Payments for) Other Financing Activities USD 0 2024-01-01 2024-12-31 2024 FY 10-K 2025-02-20 0000950170-25-024119
us-gaap ProceedsFromPaymentsToMinorityShareholders Proceeds from (Payments to) Noncontrolling Interests USD 0 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-10-29 0001743881-26-000034
us-gaap ProceedsFromRepaymentsOfRelatedPartyDebt Proceeds from (Repayments of) Related Party Debt USD 37,000 2018-01-01 2018-12-31 2020 FY 10-K 2021-02-25 0001564590-21-008969
us-gaap ProceedsFromRepaymentsOfSecuredDebt Proceeds from (Repayments of) Secured Debt USD 179,000 2019-01-01 2019-12-31 2020 FY 10-K 2021-02-25 0001564590-21-008969
us-gaap ProceedsFromSaleAndMaturityOfAvailableForSaleSecurities Proceeds from Sale and Maturity of Debt Securities, Available-for-sale USD 76.50M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-10-29 0001743881-26-000034
us-gaap ProceedsFromSaleAndMaturityOfMarketableSecurities Proceeds from Sale and Maturity of Marketable Securities USD 0 2025-01-01 2025-06-30 2025 Q2 10-Q 2025-08-05 0000950170-25-103192
us-gaap ProceedsFromSaleOfEquityMethodInvestments Proceeds from Sale of Equity Method Investments USD 34.15M 2021-01-01 2021-12-31 2021 FY 10-K 2022-02-25 0000950170-22-002030
us-gaap ProceedsFromSaleOfEquitySecuritiesFvNi ProceedsFromSaleOfEquitySecuritiesFvNi USD 0 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-24 0001743881-26-000009
us-gaap ProceedsFromSaleOfProductiveAssets Proceeds from Sale of Productive Assets USD 0 2024-01-01 2024-12-31 2024 FY 10-K 2025-02-20 0000950170-25-024119
us-gaap ProceedsFromSaleOfPropertyPlantAndEquipment Proceeds from Sale of Property, Plant, and Equipment USD 147,000 2020-01-01 2020-09-30 2021 Q3 10-Q 2021-11-04 0000950170-21-003080
us-gaap ProceedsFromStockOptionsExercised Proceeds from Stock Options Exercised USD 33.71M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-10-29 0001743881-26-000034
us-gaap ProceedsFromStockPlans Proceeds from Stock Plans USD 9.73M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-10-29 0001743881-26-000034
us-gaap ProfitLoss Net Income (Loss), Including Portion Attributable to Noncontrolling Interest USD -382.94M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-10-29 0001743881-26-000034
us-gaap PropertyPlantAndEquipmentNet Property, Plant and Equipment, Net USD 5.04M 2026-09-30 2026 Q3 10-Q 2026-10-29 0001743881-26-000034
us-gaap ReceivablesLongTermContractsOrPrograms Receivables, Long-term Contracts or Programs USD 478,000 2024-09-30 2024 Q3 10-Q 2024-11-12 0000950170-24-124577
us-gaap RedeemableNoncontrollingInterestEquityCarryingAmount Redeemable Noncontrolling Interest, Equity, Carrying Amount USD -1.36M 2026-09-30 2026 Q3 10-Q 2026-10-29 0001743881-26-000034
us-gaap RepaymentsOfLinesOfCredit Repayments of Lines of Credit USD 0 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-10-29 0001743881-26-000034
us-gaap RepaymentsOfLongTermDebt Repayments of Long-term Debt USD 459.00M 2025-01-01 2025-06-30 2025 Q2 10-Q 2025-08-05 0000950170-25-103192
us-gaap ResearchAndDevelopmentExpense Research and Development Expense USD 419.59M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-10-29 0001743881-26-000034
us-gaap ResearchAndDevelopmentInProcess Research and Development in Process USD 0 2022-01-01 2022-12-31 2022 FY 10-K 2023-02-23 0000950170-23-004145
us-gaap RestrictedCash Restricted Cash USD 2.60M 2021-12-31 2021 FY 10-K 2022-02-25 0000950170-22-002030
us-gaap RestrictedCashAndCashEquivalentsAtCarryingValue Restricted Cash and Cash Equivalents, Current USD 126,000 2025-03-31 2025 Q1 10-Q 2025-04-29 0000950170-25-060314
us-gaap RestrictedCashAndCashEquivalentsNoncurrent Restricted Cash and Cash Equivalents, Noncurrent USD 2.02M 2025-03-31 2025 Q1 10-Q 2025-04-29 0000950170-25-060314
us-gaap RestrictedCashCurrent Restricted Cash, Current USD 550,000 2026-09-30 2026 Q3 10-Q 2026-10-29 0001743881-26-000034
us-gaap RestrictedCashNoncurrent Restricted Cash, Noncurrent USD 1.57M 2026-09-30 2026 Q3 10-Q 2026-10-29 0001743881-26-000034
us-gaap RestructuringCharges Restructuring Charges USD 15.61M 2024-01-01 2024-12-31 2024 FY 10-K 2025-02-20 0000950170-25-024119
us-gaap RestructuringReserveCurrent Restructuring Reserve, Current USD 6.99M 2025-12-31 2025 FY 10-K 2026-02-24 0001743881-26-000009
us-gaap RestructuringReserveSettledWithoutCash2 Restructuring Reserve, Settled without Cash USD 1.73M 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-24 0001743881-26-000009
us-gaap RestructuringSettlementAndImpairmentProvisions Restructuring, Settlement and Impairment Provisions USD 0 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-10-29 0001743881-26-000034
us-gaap RetainedEarningsAccumulatedDeficit Retained Earnings (Accumulated Deficit) USD -4.19B 2026-09-30 2026 Q3 10-Q 2026-10-29 0001743881-26-000034
us-gaap RevenueFromContractWithCustomerExcludingAssessedTax Revenue from Contract with Customer, Excluding Assessed Tax USD 791.36M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-10-29 0001743881-26-000034
us-gaap RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability Right-of-Use Asset Obtained in Exchange for Finance Lease Liability USD 0 2022-01-01 2022-12-31 2022 FY 10-K 2023-02-23 0000950170-23-004145
us-gaap RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability Right-of-Use Asset Obtained in Exchange for Operating Lease Liability USD 11.58M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-10-29 0001743881-26-000034
us-gaap SellingGeneralAndAdministrativeExpense Selling, General and Administrative Expense USD 551.01M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-10-29 0001743881-26-000034
us-gaap SeveranceCosts1 Severance Costs USD 4.67M 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-24 0001743881-26-000009
us-gaap ShareBasedCompensation Share-based Payment Arrangement, Noncash Expense USD 117.17M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-10-29 0001743881-26-000034
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Volatility Rate pure 0.375 2019-05-17 2019-06-30 2019 Q2 10-Q 2019-08-14 0001564590-19-031927
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Risk Free Interest Rate pure 0.019 2019-05-17 2019-06-30 2019 Q2 10-Q 2019-08-14 0001564590-19-031927
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period, Intrinsic Value USD 32.20M 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-24 0001743881-26-000009
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Weighted Average Grant Date Fair Value USD/shares 30.15 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-24 0001743881-26-000009
us-gaap StockholdersEquity Stockholders' Equity Attributable to Parent USD -1.66B 2026-09-30 2026 Q3 10-Q 2026-10-29 0001743881-26-000034
us-gaap StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest USD -1.65B 2026-09-30 2026 Q3 10-Q 2026-10-29 0001743881-26-000034
us-gaap StockIssuedDuringPeriodValueEmployeeStockPurchasePlan Stock Issued During Period, Value, Employee Stock Purchase Plan USD 4.26M 2026-07-01 2026-09-30 2026 Q3 10-Q 2026-10-29 0001743881-26-000034
us-gaap StockIssuedDuringPeriodValueNewIssues Stock Issued During Period, Value, New Issues USD 932.56M 2026-07-01 2026-09-30 2026 Q3 10-Q 2026-10-29 0001743881-26-000034
us-gaap StockIssuedDuringPeriodValueShareBasedCompensation Shares Issued, Value, Share-based Payment Arrangement, after Forfeiture USD 5.90M 2026-07-01 2026-09-30 2026 Q3 10-Q 2026-10-29 0001743881-26-000034
us-gaap StockIssuedDuringPeriodValueStockOptionsExercised Stock Issued During Period, Value, Stock Options Exercised USD 16,000 2019-01-01 2019-12-31 2019 FY 10-K 2020-03-03 0001564590-20-008260
us-gaap StockRepurchasedDuringPeriodValue Stock Repurchased During Period, Value USD 47.50M 2026-07-01 2026-09-30 2026 Q3 10-Q 2026-10-29 0001743881-26-000034
us-gaap TaxCutsAndJobsActOf2017ChangeInTaxRateDeferredTaxAssetIncomeTaxExpense Tax Cuts and Jobs Act, Change in Tax Rate, Deferred Tax Asset, Income Tax Expense USD 6.80M 2017-12-30 2017-12-31 2019 FY 10-K 2020-03-03 0001564590-20-008260
us-gaap TaxesPayableCurrent Taxes Payable, Current USD 2.10M 2025-06-30 2025 Q2 10-Q 2025-08-05 0000950170-25-103192
us-gaap TemporaryEquityAccretionToRedemptionValueAdjustment Temporary Equity, Accretion to Redemption Value, Adjustment USD 9.92M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-10-29 0001743881-26-000034
us-gaap TemporaryEquityCarryingAmountIncludingPortionAttributableToNoncontrollingInterests Temporary Equity, Carrying Amount, Including Portion Attributable to Noncontrolling Interests USD 336,000 2022-03-31 2022 Q1 10-Q 2022-05-05 0000950170-22-007874
us-gaap TemporaryEquityNetIncome Temporary Equity, Net Income USD -2.85M 2026-07-01 2026-09-30 2026 Q3 10-Q 2026-10-29 0001743881-26-000034
us-gaap TemporaryEquityStockIssuedDuringPeriodValueNewIssues Temporary Equity, Stock Issued During Period, Value, New Issues USD 750,000 2025-04-01 2025-06-30 2026 Q3 10-Q 2026-10-29 0001743881-26-000034
us-gaap TransferToInvestments Transfer to Investments USD 8.77M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-10-29 0001743881-26-000034
us-gaap TreasuryStockCommonShares Treasury Stock, Common, Shares shares 11.30M 2026-09-30 2026 Q3 10-Q 2026-10-29 0001743881-26-000034
us-gaap TreasuryStockCommonValue Treasury Stock, Common, Value USD 580.77M 2026-09-30 2026 Q3 10-Q 2026-10-29 0001743881-26-000034
us-gaap TreasuryStockShares Treasury Stock, Shares shares 6.19M 2023-03-31 2023 Q1 10-Q 2023-05-04 0000950170-23-017812
us-gaap TreasuryStockValue Treasury Stock, Value USD 323.28M 2025-06-30 2025 Q2 10-Q 2025-08-05 0000950170-25-103192
us-gaap TreasuryStockValueAcquiredCostMethod Treasury Stock, Value, Acquired, Cost Method USD 200.00M 2021-01-01 2021-12-31 2023 FY 10-K 2024-02-22 0000950170-24-018811
us-gaap UnrecognizedTaxBenefits Unrecognized Tax Benefits USD 43.98M 2025-12-31 2025 FY 10-K 2026-02-24 0001743881-26-000009
us-gaap UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions Unrecognized Tax Benefits, Decrease Resulting from Prior Period Tax Positions USD 0 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-24 0001743881-26-000009
us-gaap UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued Unrecognized Tax Benefits, Income Tax Penalties and Interest Accrued USD 0 2020-12-31 2020 FY 10-K 2021-02-25 0001564590-21-008969
us-gaap UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestExpense Unrecognized Tax Benefits, Income Tax Penalties and Interest Expense USD 0 2024-01-01 2024-12-31 2024 FY 10-K 2025-02-20 0000950170-25-024119
us-gaap UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions Unrecognized Tax Benefits, Increase Resulting from Current Period Tax Positions USD 6.79M 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-24 0001743881-26-000009
us-gaap UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions Unrecognized Tax Benefits, Increase Resulting from Prior Period Tax Positions USD 318,000 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-24 0001743881-26-000009
us-gaap ValuationAllowanceDeferredTaxAssetChangeInAmount Valuation Allowance, Deferred Tax Asset, Increase (Decrease), Amount USD 240.70M 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-24 0001743881-26-000009
us-gaap VariableLeaseCost Variable Lease, Cost USD 2.69M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-10-29 0001743881-26-000034
us-gaap WarrantsNotSettleableInCashFairValueDisclosure Warrants Not Settleable in Cash, Fair Value Disclosure USD 1.60M 2023-12-31 2024 FY 10-K 2025-02-20 0000950170-25-024119
us-gaap WeightedAverageNumberOfDilutedSharesOutstanding Weighted Average Number of Shares Outstanding, Diluted shares 195.54M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-10-29 0001743881-26-000034
us-gaap WeightedAverageNumberOfShareOutstandingBasicAndDiluted Weighted Average Number of Shares Outstanding, Basic and Diluted shares 145.88M 2022-01-01 2022-03-31 2022 Q1 10-Q 2022-05-05 0000950170-22-007874
us-gaap WeightedAverageNumberOfSharesOutstandingBasic Weighted Average Number of Shares Outstanding, Basic shares 195.54M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-10-29 0001743881-26-000034

Financialist News Desk

Our desk turns official SEC filings into news. Each story is checked against the original filing. About us → · Editorial standards →